| Year |
Citation |
Score |
| 2024 |
Schöpf J, Uhrig S, Heilig CE, Lee KS, Walther T, Carazzato A, Dobberkau AM, Weichenhan D, Plass C, Hartmann M, Diwan GD, Carrero ZI, Ball CR, Hohl T, Kindler T, et al. Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions. Nature Communications. 15: 51. PMID 38168093 DOI: 10.1038/s41467-023-44360-2 |
0.347 |
|
| 2023 |
Schmutz M, Zucknick M, Schlenk RF, Mertens D, Benner A, Weichenhan D, Mücke O, Döhner K, Plass C, Bullinger L, Claus R. Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen. Clinical Epigenetics. 15: 171. PMID 37885041 DOI: 10.1186/s13148-023-01580-z |
0.319 |
|
| 2023 |
Schwartz U, Llamazares Prada M, Pohl ST, Richter M, Tamas R, Schuler M, Keller C, Mijosek V, Muley T, Schneider MA, Quast K, Hey J, Heußel CP, Warth A, Winter H, ... ... Plass C, et al. High-resolution transcriptomic and epigenetic profiling identifies novel regulators of COPD. The Embo Journal. e111272. PMID 37143403 DOI: 10.15252/embj.2022111272 |
0.338 |
|
| 2023 |
Oeing CU, Pepin ME, Saul KB, Agircan AS, Assenov Y, Merkel TS, Sedaghat-Hamedani F, Weis T, Meder B, Guan K, Plass C, Weichenhan D, Siede D, Backs J. Indirect epigenetic testing identifies a diagnostic signature of cardiomyocyte DNA methylation in heart failure. Basic Research in Cardiology. 118: 9. PMID 36939901 DOI: 10.1007/s00395-022-00954-3 |
0.31 |
|
| 2022 |
Hey J, Halperin C, Hartmann M, Mayer S, Schönung M, Lipka DB, Scherz-Shouval R, Plass C. DNA methylation landscape of tumor-associated macrophages reveals pathways, transcription factors and prognostic value relevant to triple-negative breast cancer patients. International Journal of Cancer. 152: 1226-1242. PMID 36408934 DOI: 10.1002/ijc.34364 |
0.379 |
|
| 2022 |
Halperin C, Hey J, Weichenhan D, Stein Y, Mayer S, Lutsik P, Plass C, Scherz-Shouval R. Global DNA Methylation Analysis of Cancer-Associated Fibroblasts Reveals Extensive Epigenetic Rewiring Linked with RUNX1 Upregulation in Breast Cancer Stroma. Cancer Research. OF1-OF14. PMID 36287637 DOI: 10.1158/0008-5472.CAN-22-0209 |
0.397 |
|
| 2022 |
Faltus C, Lahnsteiner A, Barrdahl M, Assenov Y, Hüsing A, Bogatyrova O, Laplana M, Johnson T, Muley T, Meister M, Warth A, Thomas M, Plass C, Kaaks R, Risch A. Identification of as a Novel AKT Activator from a Lung Cancer Epigenome-Wide Association Study (EWAS). International Journal of Molecular Sciences. 23. PMID 36142605 DOI: 10.3390/ijms231810699 |
0.332 |
|
| 2022 |
Zaremba A, Jansen P, Murali R, Mayakonda A, Riedel A, Philip M, Rose C, Schaller J, Müller H, Kutzner H, Möller I, Stadtler N, Kretz J, Sucker A, Bankfalvi A, ... ... Plass C, et al. Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors. International Journal of Cancer. PMID 35737508 DOI: 10.1002/ijc.34187 |
0.371 |
|
| 2022 |
Mundy-Bosse BL, Weigel C, Wu YZ, Abdelbaky S, Youssef Y, Casas SB, Polley N, Ernst G, Young KA, McConnell KK, Nalin AP, Wu KG, Broughton M, Lordo MR, Altynova E, ... ... Plass C, et al. Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma. Blood Cancer Discovery. 3: 154-169. PMID 35247900 DOI: 10.1158/2643-3230.BCD-21-0098 |
0.37 |
|
| 2021 |
Bakr A, Hey J, Sigismondo G, Liu CS, Sadik A, Goyal A, Cross A, Iyer RL, Müller P, Trauernicht M, Breuer K, Lutsik P, Opitz CA, Krijgsveld J, Weichenhan D, ... Plass C, et al. ID3 promotes homologous recombination via non-transcriptional and transcriptional mechanisms and its loss confers sensitivity to PARP inhibition. Nucleic Acids Research. 49: 11666-11689. PMID 34718742 DOI: 10.1093/nar/gkab964 |
0.322 |
|
| 2021 |
Pacholewska A, Grimm C, Herling CD, Lienhard M, Königs A, Timmermann B, Altmüller J, Mücke O, Reinhardt HC, Plass C, Herwig R, Hallek M, Schweiger MR. Altered DNA Methylation Profiles in Mutated CLL Patients. International Journal of Molecular Sciences. 22. PMID 34502260 DOI: 10.3390/ijms22179337 |
0.376 |
|
| 2021 |
Schamschula E, Lahnsteiner A, Assenov Y, Hagmann W, Zaborsky N, Wiederstein M, Strobl A, Stanke F, Muley T, Plass C, Tümmler B, Risch A. Disease-related blood-based differential methylation in cystic fibrosis and its representation in lung cancer revealed a regulatory locus in in lung epithelial cells. Epigenetics. 1-24. PMID 34415821 DOI: 10.1080/15592294.2021.1959976 |
0.377 |
|
| 2021 |
Català-Moll F, Ferreté-Bonastre AG, Li T, Weichenhan D, Lutsik P, Ciudad L, Álvarez-Prado ÁF, Rodríguez-Ubreva J, Klemann C, Speckmann C, Vilas-Zornoza A, Abolhassani H, Martínez-Gallo M, Dieli-Crimi R, Rivière JG, ... ... Plass C, et al. Activation-induced deaminase is critical for the establishment of DNA methylation patterns prior to the germinal center reaction. Nucleic Acids Research. 49: 5057-5073. PMID 33950194 DOI: 10.1093/nar/gkab322 |
0.357 |
|
| 2021 |
Laplana M, Bieg M, Faltus C, Melnik S, Bogatyrova O, Gu Z, Muley T, Meister M, Dienemann H, Herpel E, Amos CI, Schlesner M, Eils R, Plass C, Risch A. Differentially methylated regions within lung cancer risk loci are enriched in deregulated enhancers. Epigenetics. 1-16. PMID 33595421 DOI: 10.1080/15592294.2021.1878723 |
0.366 |
|
| 2021 |
Mancarella D, Plass C. Epigenetic signatures in cancer: proper controls, current challenges and the potential for clinical translation. Genome Medicine. 13: 23. PMID 33568205 DOI: 10.1186/s13073-021-00837-7 |
0.375 |
|
| 2021 |
Niemöller C, Wehrle J, Riba J, Claus R, Renz N, Rhein J, Bleul S, Stosch JM, Duyster J, Plass C, Lutsik P, Lipka DB, Lübbert M, Becker H. Bisulfite-free epigenomics and genomics of single cells through methylation-sensitive restriction. Communications Biology. 4: 153. PMID 33526904 DOI: 10.1038/s42003-021-01661-w |
0.381 |
|
| 2020 |
Lutsik P, Baude A, Mancarella D, Öz S, Kühn A, Toth R, Hey J, Toprak UH, Lim J, Nguyen VH, Jiang C, Mayakonda A, Hartmann M, Rosemann F, Breuer K, ... ... Plass C, et al. Globally altered epigenetic landscape and delayed osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bone. Nature Communications. 11: 5414. PMID 33110075 DOI: 10.1038/s41467-020-18955-y |
0.305 |
|
| 2020 |
Espinet E, Gu Z, Imbusch CD, Giese NA, Buscher M, Safavi M, Weisenburger S, Klein C, Vogel V, Falcone M, Insua-Rodriguez J, Reitberger M, Thiel V, Kossi SO, Muckenhuber A, ... ... Plass C, et al. Aggressive PDACs show hypomethylation of repetitive elements and the execution of an intrinsic IFN program linked to a ductal cell-of-origin. Cancer Discovery. PMID 33060108 DOI: 10.1158/2159-8290.CD-20-1202 |
0.374 |
|
| 2020 |
Scherer M, Nazarov PV, Toth R, Sahay S, Kaoma T, Maurer V, Vedeneev N, Plass C, Lengauer T, Walter J, Lutsik P. Reference-free deconvolution, visualization and interpretation of complex DNA methylation data using DecompPipeline, MeDeCom and FactorViz. Nature Protocols. 15: 3240-3263. PMID 32978601 DOI: 10.1038/s41596-020-0369-6 |
0.4 |
|
| 2020 |
Weichenhan D, Lipka DB, Lutsik P, Goyal A, Plass C. Epigenomic technologies for precision oncology. Seminars in Cancer Biology. PMID 32822861 DOI: 10.1016/J.Semcancer.2020.08.004 |
0.47 |
|
| 2020 |
Sill M, Plass C, Pfister SM, Lipka DB. Molecular tumor classification using DNA methylome analysis. Human Molecular Genetics. PMID 32657331 DOI: 10.1093/Hmg/Ddaa147 |
0.447 |
|
| 2020 |
Schlosser P, Knaus J, Schmutz M, Dohner K, Plass C, Bullinger L, Claus R, Binder H, Lubbert M, Schumacher M. Netboost: Boosting-supported Network Analysis Improves High-Dimensional Omics Prediction in Acute Myeloid Leukemia and Huntington's Disease. Ieee/Acm Transactions On Computational Biology and Bioinformatics. PMID 32365034 DOI: 10.1109/Tcbb.2020.2983010 |
0.313 |
|
| 2020 |
Kim-Wanner SZ, Assenov Y, Nair MB, Weichenhan D, Benner A, Becker N, Landwehr K, Kuner R, Sültmann H, Esteller M, Koch I, Lindner M, Meister M, Thomas M, Bieg M, ... ... Plass C, et al. Genome-wide DNA methylation profiling in early stage I lung adenocarcinoma reveals predictive aberrant methylation in the promoter region of the long non-coding RNA PLUT - an exploratory study. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 32272161 DOI: 10.1016/J.Jtho.2020.03.023 |
0.413 |
|
| 2020 |
Wierzbinska JA, Toth R, Ishaque N, Rippe K, Mallm JP, Klett LC, Mertens D, Zenz T, Hielscher T, Seifert M, Küppers R, Assenov Y, Lutsik P, Stilgenbauer S, Roessner PM, ... ... Plass C, et al. Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL. Genome Medicine. 12: 29. PMID 32188505 DOI: 10.1186/S13073-020-00724-7 |
0.491 |
|
| 2020 |
Prada ML, Hernandez EE, Mijosek V, Schwartz U, Tamas R, Richter M, Behrendt A, Pohl S, Benz N, Muley T, Warth A, Herth F, Koch I, Karmouty-Quintana H, Mertens T, ... ... Plass C, et al. Versatile workflow for storage, characterization and cell-type resolved transcriptional and epigenetic profiling of human lung samples. Erj Open Research. 6. DOI: 10.1183/23120541.Lsc-2020.44 |
0.362 |
|
| 2020 |
Boldrin E, Gaffo E, Boer J, Demir S, Zinngrebe J, Claus R, Plass C, Boer MLd, Debatin K, Kronnie Gt, Bortoluzzi S, Meyer LH. Abstract 2541: MicroRNA-497~195 cluster suppresses acute lymphoblastic leukemia growth by targeting CCND3/CDK4 and inhibiting cell cycle progression Cancer Research. 80: 2541-2541. DOI: 10.1158/1538-7445.Am2020-2541 |
0.312 |
|
| 2019 |
Emperle M, Adam S, Kunert S, Dukatz M, Baude A, Plass C, Rathert P, Bashtrykov P, Jeltsch A. Mutations of R882 change flanking sequence preferences of the DNA methyltransferase DNMT3A and cellular methylation patterns. Nucleic Acids Research. PMID 31620784 DOI: 10.1093/Nar/Gkz911 |
0.428 |
|
| 2019 |
Wojdacz TK, Amarasinghe HE, Kadalayil L, Beattie A, Forster J, Blakemore SJ, Parker H, Bryant D, Larrayoz M, Clifford R, Robbe P, Davis ZA, Else M, Howard DR, Stamatopoulos B, ... ... Plass C, et al. Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials. Blood Advances. 3: 2474-2481. PMID 31434681 DOI: 10.1182/Bloodadvances.2019000237 |
0.378 |
|
| 2019 |
Schmitt K, Molfenter B, Koerich Laureano N, Tawk B, Bieg M, Pastor Hostench X, Weichenhan D, Ullrich ND, Shang V, Richter D, Stögbauer F, Schroeder L, de Bem Prunes B, Visioli F, Varvaki Rados P, ... ... Plass C, et al. Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer. International Journal of Cancer. PMID 31135957 DOI: 10.1002/Ijc.32481 |
0.529 |
|
| 2019 |
Orouji E, Federico A, Larribère L, Novak D, Lipka DB, Assenov Y, Sachindra, Hüser L, Granados K, Gebhardt C, Plass C, Umansky V, Utikal J. Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target. International Journal of Cancer. PMID 31131878 DOI: 10.1002/Ijc.32432 |
0.44 |
|
| 2019 |
Souren NY, Gerdes LA, Lutsik P, Gasparoni G, Beltrán E, Salhab A, Kümpfel T, Weichenhan D, Plass C, Hohlfeld R, Walter J. DNA methylation signatures of monozygotic twins clinically discordant for multiple sclerosis. Nature Communications. 10: 2094. PMID 31064978 DOI: 10.1038/S41467-019-09984-3 |
0.388 |
|
| 2019 |
Weigel C, Chaisaingmongkol J, Assenov Y, Kuhmann C, Winkler V, Santi I, Bogatyrova O, Kaucher S, Bermejo JL, Leung SY, Chan TL, Lasitschka F, Bohrer MH, Marx A, Haußen RH, ... ... Plass C, et al. DNA methylation at an enhancer of the three prime repair exonuclease 2 gene (TREX2) is linked to gene expression and survival in laryngeal cancer. Clinical Epigenetics. 11: 67. PMID 31053176 DOI: 10.1186/S13148-019-0666-5 |
0.469 |
|
| 2019 |
Weichenhan D, Imbusch CD, Wang Q, Brors B, Plass C. Generation of Whole Genome Bisulfite Sequencing Libraries from Very Low DNA Input. Methods in Molecular Biology (Clifton, N.J.). 1956: 229-248. PMID 30779037 DOI: 10.1007/978-1-4939-9151-8_10 |
0.448 |
|
| 2019 |
Fellenberg J, Sähr H, Mancarella D, Plass C, Lindroth AM, Westhauser F, Lehner B, Ewerbeck V. Knock-down of oncohistone H3F3A-G34W counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells. Cancer Letters. 448: 61-69. PMID 30742944 DOI: 10.1016/J.Canlet.2019.02.001 |
0.327 |
|
| 2019 |
Krais AM, Park YJ, Reifenberger G, Meister M, Plass C, Schmeiser HH. Sensitive detection of hydroxymethylcytosine levels in normal and neoplastic cells and tissues. Electrophoresis. PMID 30724377 DOI: 10.1002/Elps.201800523 |
0.423 |
|
| 2019 |
Haller F, Bieg M, Will R, Körner C, Weichenhan D, Bott A, Ishaque N, Lutsik P, Moskalev EA, Mueller SK, Bähr M, Woerner A, Kaiser B, Scherl C, Haderlein M, ... ... Plass C, et al. Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands. Nature Communications. 10: 368. PMID 30664630 DOI: 10.1038/S41467-018-08069-X |
0.381 |
|
| 2019 |
Goeppert B, Toth R, Singer S, Albrecht T, Lipka DB, Lutsik P, Brocks D, Baehr M, Muecke O, Assenov Y, Gu L, Endris V, Stenzinger A, Mehrabi A, Schirmacher P, ... Plass C, et al. Integrative analysis defines distinct prognostic subgroups of intrahepatic cholangiocarcinoma. Hepatology (Baltimore, Md.). PMID 30615206 DOI: 10.1002/Hep.30493 |
0.456 |
|
| 2019 |
Meyer J, Schönung M, Flotho C, Olshen AB, Hartmann M, Plass C, Okuno Y, Takahashi Y, Murakami N, Wakamatsu M, Loh ML, Niemeyer CM, Muramatsu H, Lipka DB, Stieglitz E. DNA Methylation As a Biomarker of Outcome in JMML: An International Effort Towards Clinical Implementation Blood. 134: 1693-1693. DOI: 10.1182/Blood-2019-131279 |
0.394 |
|
| 2019 |
Staeble S, Kraemer S, Langstein J, Bogeska R, Hartmann M, Schoenung M, Czeh M, Knoch J, Anstee N, Haas S, Mahmoud A, Graesel J, Huebschmann D, Feuerbach L, Dieter W, ... ... Plass C, et al. Deconvolution of Hematopoietic Commitment Decisions By Genome-Wide Analysis of Progressive DNA Methylation Changes Blood. 134: 1179-1179. DOI: 10.1182/Blood-2019-124429 |
0.444 |
|
| 2019 |
Stäble S, Krämer S, Langstein J, Bogeska R, Hartmann M, Schönung M, Anstee N, Haas S, Weichenhan D, Czeh M, Gräsel J, Hübschmann D, Rosenbauer F, Plass C, Schlesner M, et al. S137 DNA METHYLATION DYNAMICS IDENTIFY LINEAGE-SPECIFIC REGULATION PATTERNS OF HEMATOPOIETIC DIFFERENTIATION Hemasphere. 3: 20. DOI: 10.1097/01.HS9.0000558768.40633.0A |
0.331 |
|
| 2018 |
Gerhauser C, Favero F, Risch T, Simon R, Feuerbach L, Assenov Y, Heckmann D, Sidiropoulos N, Waszak SM, Hübschmann D, Urbanucci A, Girma EG, Kuryshev V, Klimczak LJ, Saini N, ... ... Plass C, et al. Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories. Cancer Cell. 34: 996-1011.e8. PMID 30537516 DOI: 10.1016/J.Ccell.2018.10.016 |
0.32 |
|
| 2018 |
Lipka DB, Lutsik P, Plass C. From Basic Knowledge to Effective Therapies. Cancer Cell. 34: 871-873. PMID 30537508 DOI: 10.1016/J.Ccell.2018.11.013 |
0.329 |
|
| 2018 |
Lim J, Park JH, Baude A, Fellenberg J, Zustin J, Haller F, Krücken I, Kang HG, Park YJ, Plass C, Lindroth AM. Transcriptome and protein interaction profiling in cancer cells with mutations in histone H3.3. Scientific Data. 5: 180283. PMID 30532024 DOI: 10.1038/Sdata.2018.283 |
0.345 |
|
| 2018 |
Blagitko-Dorfs N, Schlosser P, Greve G, Pfeifer D, Meier R, Baude A, Brocks D, Plass C, Lübbert M. Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene body demethylation. Leukemia. PMID 30470836 DOI: 10.1038/S41375-018-0293-8 |
0.481 |
|
| 2018 |
Grigoryan A, Guidi N, Senger K, Liehr T, Soller K, Marka G, Vollmer A, Markaki Y, Leonhardt H, Buske C, Lipka DB, Plass C, Zheng Y, Mulaw MA, Geiger H, et al. LaminA/C regulates epigenetic and chromatin architecture changes upon aging of hematopoietic stem cells. Genome Biology. 19: 189. PMID 30404662 DOI: 10.1186/S13059-018-1557-3 |
0.395 |
|
| 2018 |
Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Research. PMID 30341162 DOI: 10.1101/Gr.239244.118 |
0.371 |
|
| 2018 |
Majumder S, Ghoshal K, Datta J, Bai S, Dong X, Quan N, Plass C, Jacob ST. Role of DNA methyltransferases and methyl CpG-binding proteins in gene silencing in a rat hepatoma. The Journal of Biological Chemistry. 293: 12948. PMID 30120152 DOI: 10.1074/Jbc.W118.004970 |
0.453 |
|
| 2018 |
Rosenquist R, Esteller M, Plass C. Introduction: Epigenetics in cancer. Seminars in Cancer Biology. PMID 29990621 DOI: 10.1016/J.Semcancer.2018.07.002 |
0.372 |
|
| 2018 |
Melnik S, Dvornikov D, Müller-Decker K, Depner S, Stannek P, Meister M, Warth A, Thomas M, Muley T, Risch A, Plass C, Klingmüller U, Niehrs C, Glinka A. Cancer cell specific inhibition of Wnt/β-catenin signaling by forced intracellular acidification. Cell Discovery. 4: 37. PMID 29977599 DOI: 10.1038/S41421-018-0033-2 |
0.344 |
|
| 2018 |
Schlereth K, Weichenhan D, Bauer T, Heumann T, Giannakouri E, Lipka D, Jaeger S, Schlesner M, Aloy P, Eils R, Plass C, Augustin HG. The transcriptomic and epigenetic map of vascular quiescence in the continuous lung endothelium. Elife. 7. PMID 29749927 DOI: 10.7554/Elife.34423 |
0.432 |
|
| 2018 |
Daskalakis M, Brocks D, Sheng YH, Islam MS, Ressnerova A, Assenov Y, Milde T, Oehme I, Witt O, Goyal A, Kühn A, Hartmann M, Weichenhan D, Jung M, Plass C. Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitors. Cell Cycle (Georgetown, Tex.). 1-31. PMID 29633898 DOI: 10.1080/15384101.2018.1442623 |
0.367 |
|
| 2018 |
Wirthschaft P, Bode J, Simon AEM, Hoffmann E, van Laack R, Krüwel T, Dietrich F, Bucher D, Hahn A, Sahm F, Breckwoldt MO, Kurz FT, Hielscher T, Fischer B, Dross N, ... ... Plass C, et al. A PRDX1-p38α heterodimer amplifies MET-driven invasion of IDH-wildtype and IDH-mutant gliomas. International Journal of Cancer. PMID 29582423 DOI: 10.1002/Ijc.31404 |
0.36 |
|
| 2018 |
Mansouri L, Wierzbinska JA, Plass C, Rosenquist R. Epigenetic deregulation in chronic lymphocytic leukemia: clinical and biological impact. Seminars in Cancer Biology. PMID 29427646 DOI: 10.1016/J.Semcancer.2018.02.001 |
0.543 |
|
| 2018 |
Weichenhan D, Wang Q, Adey A, Wolf S, Shendure J, Eils R, Plass C. Tagmentation-Based Library Preparation for Low DNA Input Whole Genome Bisulfite Sequencing. Methods in Molecular Biology (Clifton, N.J.). 1708: 105-122. PMID 29224141 DOI: 10.1007/978-1-4939-7481-8_6 |
0.388 |
|
| 2018 |
Schwartz U, Prada ML, Richter M, Tamas R, Muley T, Warth A, Weichenhan D, Brors B, Quast K, Wyatt D, Plass C, Jurkowska R. DNA methylation and gene expression changes in human lung fibroblasts occur already in mild COPD and progress with disease development European Respiratory Journal. 52. DOI: 10.1183/13993003.Congress-2018.Pa926 |
0.472 |
|
| 2018 |
Weigel C, Assenov Y, Imbusch C, Wang Q, Beekman R, Giacopelli B, Wu Y, Brocks D, Dieter W, Odilia P, Schmezer P, Brors B, Mertens D, Rippe K, Rassenti LZ, ... ... Plass C, et al. Recurrent Mutations in EGR2 Direct Specific Epigenetic Reconfiguration in Chronic Lymphocytic Leukemia Blood. 132: 650-650. DOI: 10.1182/Blood-2018-99-119070 |
0.427 |
|
| 2018 |
Wierzbinska JA, Toth R, Ishaque N, Mallm J, Rippe K, Mertens D, Hielscher T, Zenz T, Seifert M, Küppers R, Assenov Y, Stilgenbauer S, Byrd JC, Oakes CC, Lipka DB, ... Plass C, et al. Modeling of the Epigenome of the Cell-of-Origin Identifies Cancer-Specific DNA Methylation Patterns in CLL Blood. 132: 3885-3885. DOI: 10.1182/Blood-2018-99-115941 |
0.479 |
|
| 2018 |
Schoenung M, Stieglitz E, Muramatsu H, Murakami N, Hartmann M, Wiesenfarth M, Okuno Y, Olshen AB, Plass C, Loh ML, Niemeyer C, Flotho C, Lipka DB. DNA Methylation Subgroups in Juvenile Myelomonocytic Leukemia: An International Collaborative Analysis and Development of a Common Diagnostic Platform Blood. 132: 3093-3093. DOI: 10.1182/Blood-2018-99-114918 |
0.465 |
|
| 2018 |
Meier R, Greve G, Niemöller C, Becker H, Ma T, Langova R, Grüning B, Feuerbach L, Lipka DB, Duyster J, Brors B, Plass C, Lübbert M. Cooperative Effects of a Dnmt Inhibitor and All-Trans Retinoic Acid in an AML Cell Line Model Lacking PML-Rara Blood. 132: 1359-1359. DOI: 10.1182/Blood-2018-99-113450 |
0.354 |
|
| 2018 |
Wojdacz TK, Amarasinghe HE, Rose-Zerilli MJ, Beattie A, Forster J, Kadalayil L, Blakemore S, Parker H, Larrayoz M, Clifford R, Davis Z, Else M, Cohen D, Steele AJ, Rosenquist R, ... ... Plass C, et al. Abstract 3306: The clinical importance of DNA methylation signatures in chronic lymphocytic leukemia patients treated with chemo-immunotherapy Cancer Research. 78: 3306-3306. DOI: 10.1158/1538-7445.Am2018-3306 |
0.425 |
|
| 2017 |
Lipka DB, Witte T, Toth R, Yang J, Wiesenfarth M, Nöllke P, Fischer A, Brocks D, Gu Z, Park J, Strahm B, Wlodarski M, Yoshimi A, Claus R, Lübbert M, ... ... Plass C, et al. RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia. Nature Communications. 8: 2126. PMID 29259247 DOI: 10.1038/S41467-017-02177-W |
0.39 |
|
| 2017 |
Stieglitz E, Mazor T, Olshen AB, Geng H, Gelston LC, Akutagawa J, Lipka DB, Plass C, Flotho C, Chehab FF, Braun BS, Costello JF, Loh ML. Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia. Nature Communications. 8: 2127. PMID 29259179 DOI: 10.1038/S41467-017-02178-9 |
0.412 |
|
| 2017 |
Dietrich S, Oleś M, Lu J, Sellner L, Anders S, Velten B, Wu B, Hüllein J, da Silva Liberio M, Walther T, Wagner L, Rabe S, Ghidelli-Disse S, Bantscheff M, Oleś AK, ... ... Plass C, et al. Drug-perturbation-based stratification of blood cancer. The Journal of Clinical Investigation. PMID 29227286 DOI: 10.1172/Jci93801 |
0.403 |
|
| 2017 |
Delacher M, Imbusch CD, Weichenhan D, Breiling A, Hotz-Wagenblatt A, Träger U, Hofer AC, Kägebein D, Wang Q, Frauhammer F, Mallm JP, Bauer K, Herrmann C, Lang PA, Brors B, ... Plass C, et al. Corrigendum: Genome-wide DNA-methylation landscape defines specialization of regulatory T cells in tissues. Nature Immunology. 18: 1361. PMID 29144491 DOI: 10.1038/Ni1217-1361B |
0.431 |
|
| 2017 |
Jäkel C, Bergmann F, Toth R, Assenov Y, van der Duin D, Strobel O, Hank T, Klöppel G, Dorrell C, Grompe M, Moss J, Dor Y, Schirmacher P, Plass C, Popanda O, et al. Genome-wide genetic and epigenetic analyses of pancreatic acinar cell carcinomas reveal aberrations in genome stability. Nature Communications. 8: 1323. PMID 29109526 DOI: 10.1038/S41467-017-01118-X |
0.48 |
|
| 2017 |
Lim J, Park JH, Baude A, Yoo Y, Lee YK, Schmidt CR, Park JB, Fellenberg J, Zustin J, Haller F, Krücken I, Kang HG, Park YJ, Plass C, Lindroth AM. The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing. Scientific Reports. 7: 13459. PMID 29044188 DOI: 10.1038/S41598-017-13887-Y |
0.39 |
|
| 2017 |
Wolf C, Garding A, Filarsky K, Bahlo J, Robrecht S, Becker N, Zucknick M, Rouhi A, Weigel A, Claus R, Weichenhan D, Eichhorst B, Fischer K, Hallek M, Kuchenbauer F, ... Plass C, et al. NFATC1 activation by DNA hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutinib. International Journal of Cancer. PMID 28921505 DOI: 10.1002/Ijc.31057 |
0.459 |
|
| 2017 |
Valinciute G, Weigel C, Veldwijk MR, Oakes CC, Herskind C, Wenz F, Plass C, Schmezer P, Popanda O. BET-bromodomain inhibitors modulate epigenetic patterns at the diacylglycerol kinase alpha enhancer associated with radiation-induced fibrosis. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28916223 DOI: 10.1016/J.Radonc.2017.08.028 |
0.319 |
|
| 2017 |
Meder B, Haas J, Sedaghat-Hamedani F, Kayvanpour E, Frese K, Lai A, Nietsch R, Scheiner C, Mester S, Martins Bordalo D, Amr A, Dietrich C, Pils D, Siede D, Hund H, ... ... Plass C, et al. Epigenome-Wide Association Study Identifies Cardiac Gene Patterning and A Novel Class of Biomarkers for Heart Failure. Circulation. PMID 28838933 DOI: 10.1161/Circulationaha.117.027355 |
0.434 |
|
| 2017 |
Delacher M, Imbusch CD, Weichenhan D, Breiling A, Hotz-Wagenblatt A, Träger U, Hofer AC, Kägebein D, Wang Q, Frauhammer F, Mallm JP, Bauer K, Herrmann C, Lang PA, Brors B, ... Plass C, et al. Genome-wide DNA-methylation landscape defines specialization of regulatory T cells in tissues. Nature Immunology. PMID 28783152 DOI: 10.1038/Ni.3799 |
0.421 |
|
| 2017 |
Heilmann K, Toth R, Bossmann C, Klimo K, Plass C, Gerhauser C. Genome-wide screen for differentially methylated long noncoding RNAs identifies Esrp2 and lncRNA Esrp2-as regulated by enhancer DNA methylation with prognostic relevance for human breast cancer. Oncogene. PMID 28759043 DOI: 10.1038/Onc.2017.246 |
0.533 |
|
| 2017 |
Fluhr S, Krombholz CF, Meier A, Epting T, Mücke O, Plass C, Niemeyer CM, Flotho C. Epigenetic dysregulation of the erythropoietic transcription factor KLF1 and the beta-like globin locus in juvenile myelomonocytic leukemia. Epigenetics. 0. PMID 28749240 DOI: 10.1080/15592294.2017.1356959 |
0.502 |
|
| 2017 |
Brocks D, Schmidt CR, Daskalakis M, Jang HS, Shah NM, Li D, Li J, Zhang B, Hou Y, Laudato S, Lipka DB, Schott J, Bierhoff H, Assenov Y, Helf M, ... ... Plass C, et al. DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats. Nature Genetics. PMID 28604729 DOI: 10.1038/Ng.3889 |
0.425 |
|
| 2017 |
Koelsche C, Schrimpf D, Tharun L, Roth E, Sturm D, Jones DTW, Renker EK, Sill M, Baude A, Sahm F, Capper D, Bewerunge-Hudler M, Hartmann W, Kulozik AE, Petersen I, ... ... Plass C, et al. Histone 3.3 hotspot mutations in conventional osteosarcomas: a comprehensive clinical and molecular characterization of six H3F3A mutated cases. Clinical Sarcoma Research. 7: 9. PMID 28484590 DOI: 10.1186/S13569-017-0075-5 |
0.31 |
|
| 2017 |
Bernhardt M, Novak D, Assenov Y, Orouji E, Knappe N, Weina K, Reith M, Larribere L, Gebhardt C, Plass C, Umansky V, Utikal J. Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response. Stem Cell Reports. PMID 28392221 DOI: 10.1016/J.Stemcr.2017.03.007 |
0.364 |
|
| 2017 |
Dewi DL, Mohapatra SR, Blanco Cabañes S, Adam I, Somarribas Patterson LF, Berdel B, Kahloon M, Thürmann L, Loth S, Heilmann K, Weichenhan D, Mücke O, Heiland I, Wimberger P, Kuhlmann JD, ... ... Plass C, et al. Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer. Oncoimmunology. 6: e1274477. PMID 28344890 DOI: 10.1080/2162402X.2016.1274477 |
0.347 |
|
| 2017 |
Yoo Y, Park JH, Weigel C, Liesenfeld DB, Weichenhan D, Plass C, Seo DG, Lindroth AM, Park YJ. TET-mediated hydroxymethylcytosine at the Pparγ locus is required for initiation of adipogenic differentiation. International Journal of Obesity (2005). PMID 28100914 DOI: 10.1038/Ijo.2017.8 |
0.451 |
|
| 2017 |
Weigel C, Chaisaingmongkol J, Kuhmann C, Santi I, Winkler V, Bogatyrova O, Bermejo JL, Chan TL, Lasitschka F, Bohrer MH, Marx A, Autschbach F, Haußen RH, Dyckhoff G, Delank K, ... ... Plass C, et al. Abstract 3364: DNA methylation loss at an enhancer site of the DNA repair geneTREX2is an epigenetic feature in multiple cancers Cancer Research. 77: 3364-3364. DOI: 10.1158/1538-7445.Am2017-3364 |
0.556 |
|
| 2017 |
Lipka D, Witte T, Toth R, Yang J, Baude A, Wiesenfarth M, Brocks D, Mücke O, Nöllke P, Assenov Y, Schlesner M, Niemeyer C, Plass C, Flotho C. Genome-Wide DNA Methylation Profiling Reveals Distinct Molecular Subgroups of Juvenile Myelomonocytic Leukemia with Clinical Significance Leukemia Research. 55. DOI: 10.1016/S0145-2126(17)30147-9 |
0.461 |
|
| 2017 |
Faltus C, Assenov Y, Barrdahl M, Laplana M, Bogatyrova O, Hüsing A, Johnson T, Meister M, Muley T, Warth A, Plass C, Kaaks R, Risch A. P2.01-036 Identification of a Novel Oncogenic Ubiquitin Ligase from a Lung Cancer Epigenome-Wide Association Study (EWAS) Journal of Thoracic Oncology. 12: S806-S807. DOI: 10.1016/J.Jtho.2016.11.1088 |
0.322 |
|
| 2017 |
Bamezai S, Mulaw M, Vegi N, Zhou F, Rohde C, Döhner K, Döhner H, Feuring-Buske M, Höll J, Kloetgen A, Borkhardt A, Aravin A, Plass C, Müller-Tidow C, Rawat V, et al. Aberrantly expressed stem cell associated protein PIWIL4 acts as a piRNA binding, epigenetically active and growth regulatory factor in human acute myeloid leukemia Experimental Hematology. 53: S129. DOI: 10.1016/J.Exphem.2017.06.326 |
0.338 |
|
| 2016 |
Chan D, McGraw S, Klein K, Wallock LM, Konermann C, Plass C, Chan P, Robaire B, Jacob RA, Greenwood CM, Trasler JM. Stability of the human sperm DNA methylome to folic acid fortification and short-term supplementation. Human Reproduction (Oxford, England). PMID 27994001 DOI: 10.1093/Humrep/Dew308 |
0.324 |
|
| 2016 |
Drennan S, D'Avola A, Gao Y, Weigel C, Chrysostomou E, Steele AJ, Zenz T, Plass C, Johnson PW, Williams AP, Packham G, Stevenson FK, Oakes CC, Forconi F. IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locus. Leukemia. PMID 27890932 DOI: 10.1038/Leu.2016.356 |
0.361 |
|
| 2016 |
Schliesser MG, Claus R, Hielscher T, Grimm C, Weichenhan D, Blaes J, Wiestler B, Hau P, Schramm J, Sahm F, Weiß EK, Weiler M, Baer C, Schmidt-Graf F, Schackert G, ... ... Plass C, et al. Prognostic relevance of miRNA-155 methylation in anaplastic glioma. Oncotarget. PMID 27880937 DOI: 10.18632/Oncotarget.13452 |
0.396 |
|
| 2016 |
Henrich KO, Bender S, Saadati M, Dreidax D, Gartlgruber M, Shao C, Herrmann C, Wiesenfarth M, Parzonka M, Wehrmann L, Fischer M, Duffy DJ, Bell E, Torkov A, Schmezer P, ... Plass C, et al. Integrative Genome-Scale Analysis Identifies Epigenetic Mechanisms of Transcriptional Deregulation in Unfavorable Neuroblastomas. Cancer Research. 76: 5523-37. PMID 27635046 DOI: 10.1158/0008-5472.Can-15-2507 |
0.535 |
|
| 2016 |
Schmidt-Wolf IG, Plass C, Byrd JC, Frevel K, Pietsch T, Waha A. Assessment of Promoter Methylation Identifies PTCH as a Putative Tumor-suppressor Gene in Human CLL. Anticancer Research. 36: 4515-9. PMID 27630290 DOI: 10.21873/Anticanres.10998 |
0.459 |
|
| 2016 |
Goeppert B, Ernst C, Baer C, Roessler S, Renner M, Mehrabi A, Hafezi M, Pathil A, Warth A, Stenzinger A, Weichert W, Bähr M, Will R, Schirmacher P, Plass C, et al. Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinoma. Epigenetics. 0. PMID 27593557 DOI: 10.1080/15592294.2016.1227899 |
0.437 |
|
| 2016 |
Moran S, Martínez-Cardús A, Sayols S, Musulén E, Balañá C, Estival-Gonzalez A, Moutinho C, Heyn H, Diaz-Lagares A, de Moura MC, Stella GM, Comoglio PM, Ruiz-Miró M, Matias-Guiu X, Pazo-Cid R, ... ... Plass C, et al. Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis. The Lancet. Oncology. PMID 27575023 DOI: 10.1016/S1470-2045(16)30297-2 |
0.399 |
|
| 2016 |
Merkle R, Steiert B, Salopiata F, Depner S, Raue A, Iwamoto N, Schelker M, Hass H, Wäsch M, Böhm ME, Mücke O, Lipka DB, Plass C, Lehmann WD, Kreutz C, et al. Identification of Cell Type-Specific Differences in Erythropoietin Receptor Signaling in Primary Erythroid and Lung Cancer Cells. Plos Computational Biology. 12: e1005049. PMID 27494133 DOI: 10.1371/Journal.Pcbi.1005049 |
0.359 |
|
| 2016 |
Trump S, Bieg M, Gu Z, Thürmann L, Bauer T, Bauer M, Ishaque N, Röder S, Gu L, Herberth G, Lawerenz C, Borte M, Schlesner M, Plass C, Diessl N, et al. Prenatal maternal stress and wheeze in children: novel insights into epigenetic regulation. Scientific Reports. 6: 28616. PMID 27349968 DOI: 10.1038/Srep28616 |
0.341 |
|
| 2016 |
D'Avola A, Drennan S, Tracy I, Henderson I, Chiecchio L, Larrayoz M, Rose-Zerilli M, Strefford J, Plass C, Johnson PW, Steele AJ, Packham G, Stevenson FK, Oakes CC, Forconi F. Surface IgM expression and function associate with clinical behavior, genetic abnormalities and DNA methylation in CLL. Blood. PMID 27301861 DOI: 10.1182/Blood-2016-03-707786 |
0.407 |
|
| 2016 |
Fluhr S, Boerries M, Busch H, Symeonidi A, Witte T, Lipka DB, Mücke O, Nöllke P, Krombholz CF, Niemeyer CM, Plass C, Flotho C. CREBBP is a target of epigenetic, but not genetic, modification in juvenile myelomonocytic leukemia. Clinical Epigenetics. 8: 50. PMID 27158276 DOI: 10.1186/S13148-016-0216-3 |
0.505 |
|
| 2016 |
Chen TL, Gupta N, Lehman A, Ruppert AS, Yu L, Oakes CC, Claus R, Plass C, Maddocks KJ, Andritsos L, Jones JA, Lucas DM, Johnson AJ, Byrd JC, Hertlein E. Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemia. Oncotarget. PMID 27107422 DOI: 10.18632/Oncotarget.8760 |
0.412 |
|
| 2016 |
Filarsky K, Garding A, Becker N, Wolf C, Zucknick M, Claus R, Weichenhan D, Plass C, Döhner H, Stilgenbauer S, Lichter P, Mertens D. Krüppel-like factor 4 (KLF4) inactivation in chronic lymphocytic leukemia correlates with promoter DNA-methylation and can be reversed by inhibition of NOTCH signaling. Haematologica. 101: e249-53. PMID 27081174 DOI: 10.3324/Haematol.2015.138172 |
0.481 |
|
| 2016 |
Bauer T, Trump S, Ishaque N, Thürmann L, Gu L, Bauer M, Bieg M, Gu Z, Weichenhan D, Mallm JP, Röder S, Herberth G, Takada E, Mücke O, Winter M, ... ... Plass C, et al. Environment-induced epigenetic reprogramming in genomic regulatory elements in smoking mothers and their children. Molecular Systems Biology. 12: 861. PMID 27013061 DOI: 10.15252/Msb.20156520 |
0.471 |
|
| 2016 |
Weigel C, Veldwijk MR, Oakes CC, Seibold P, Slynko A, Liesenfeld DB, Rabionet M, Hanke SA, Wenz F, Sperk E, Benner A, Rösli C, Sandhoff R, Assenov Y, Plass C, et al. Epigenetic regulation of diacylglycerol kinase alpha promotes radiation-induced fibrosis. Nature Communications. 7: 10893. PMID 26964756 DOI: 10.1038/ncomms10893 |
0.332 |
|
| 2016 |
Mock A, Geisenberger C, Orlik C, Warta R, Schwager C, Jungk C, Dutruel C, Geiselhart L, Weichenhan D, Zucknick M, Nied AK, Friauf S, Exner J, Capper D, Hartmann C, ... ... Plass C, et al. LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patients. International Journal of Cancer. PMID 26934681 DOI: 10.1002/Ijc.30069 |
0.486 |
|
| 2016 |
Wilhelm T, Lipka DB, Witte T, Wierzbinska JA, Fluhr S, Helf M, Mücke O, Claus R, Konermann C, Nöllke P, Niemeyer CM, Flotho C, Plass C. Epigenetic silencing of AKAP12 in juvenile myelomonocytic leukemia. Epigenetics. 0. PMID 26891149 DOI: 10.1080/15592294.2016.1145327 |
0.489 |
|
| 2016 |
Kostareli E, Hielscher T, Zucknick M, Baboci L, Wichmann G, Holzinger D, Mücke O, Pawlita M, Del Mistro A, Boscolo-Rizzo P, Da Mosto MC, Tirelli G, Plinkert P, Dietz A, Plass C, et al. Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients. Epigenetics. 11: 61-73. PMID 26786582 DOI: 10.1080/15592294.2015.1137414 |
0.351 |
|
| 2016 |
Oakes CC, Seifert M, Assenov Y, Gu L, Przekopowitz M, Ruppert AS, Wang Q, Imbusch CD, Serva A, Koser SD, Brocks D, Lipka DB, Bogatyrova O, Weichenhan D, Brors B, ... ... Plass C, et al. DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia. Nature Genetics. PMID 26780610 DOI: 10.1038/Ng.3488 |
0.459 |
|
| 2016 |
Daskalakis M, Brocks D, Schmidt C, Li D, Li J, Jang HS, Zhang B, Lipka DB, Schott J, Bierhoff H, Assenov Y, Helf M, Ressnerova A, Lindroth A, Haas S, ... ... Plass C, et al. Epigenetic Drug Treatment Globally Induces Cryptic Transcription Start Sites Encoded in Long Terminal Repeats Blood. 128: 3931-3931. DOI: 10.1182/Blood.V128.22.3931.3931 |
0.451 |
|
| 2016 |
Bock C, Halbritter F, Carmona FJ, Tierling S, Datlinger P, Assenov Y, Berdasco M, Bergmann AK, Booher K, Busato F, Campan M, Dahl C, Dahmcke CM, Diep D, Fernández AF, ... ... Plass C, et al. Quantitative comparison of DNA methylation assays for biomarker development and clinical applications Nature Biotechnology. 34: 726-737. DOI: 10.1038/Nbt.3605 |
0.43 |
|
| 2016 |
Toth R, Goeppert B, Lipka D, Brocks D, Baehr M, Roessler S, Schirmacher P, Plass C, Weichenhan D. Integrative analysis of methylation and copy number alteration reveals molecular subgroups of cholangiocarcinoma European Journal of Cancer. 61: S27. DOI: 10.1016/S0959-8049(16)61083-3 |
0.417 |
|
| 2016 |
Siebenkäs C, Bergmann F, Plass C, Popanda O, Schmezer P. Epigenetic and genetic characterization of pancreatic acinar cell carcinoma European Journal of Cancer. 61: S27. DOI: 10.1016/S0959-8049(16)61082-1 |
0.331 |
|
| 2016 |
Siebert R, Gerhäuser C, Simon R, Wagener R, Weber UD, Sauter G, Plass C, Lichter P. Internationales Krebsgenomkonsortium (ICGC)@@@International Cancer Genome Consortium (ICGC): Sequenzbasierte Analyse und genomweite Katalogisierung von Aberrationen bei Tumoren als Grundlage für die Präzisionsmedizin@@@Sequence-based analysis and genome-wide cataloging of aberrations in tumors as a basis for precision medicine Medizinische Genetik. 28: 416-423. DOI: 10.1007/S11825-017-0117-7 |
0.321 |
|
| 2015 |
Schramm A, Köster J, Assenov Y, Althoff K, Peifer M, Mahlow E, Odersky A, Beisser D, Ernst C, Henssen AG, Stephan H, Schröder C, Heukamp L, Engesser A, Kahlert Y, ... ... Plass C, et al. Mutational dynamics between primary and relapse neuroblastomas. Nature Genetics. PMID 26121086 DOI: 10.1038/Ng.3349 |
0.403 |
|
| 2015 |
Baer C, Oakes CC, Ruppert AS, Claus R, Kim-Wanner SZ, Mertens D, Zenz T, Stilgenbauer S, Byrd JC, Plass C. Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia. International Journal of Cancer. Journal International Du Cancer. 137: 1352-61. PMID 25704289 DOI: 10.1002/Ijc.29491 |
0.338 |
|
| 2015 |
McGraw S, Zhang JX, Farag M, Chan D, Caron M, Konermann C, Oakes CC, Mohan KN, Plass C, Pastinen T, Bourque G, Chaillet JR, Trasler JM. Transient DNMT1 suppression reveals hidden heritable marks in the genome. Nucleic Acids Research. 43: 1485-97. PMID 25578964 DOI: 10.1093/Nar/Gku1386 |
0.497 |
|
| 2015 |
Gu L, Frommel SC, Oakes CC, Simon R, Grupp K, Gerig CY, Bär D, Robinson MD, Baer C, Weiss M, Gu Z, Schapira M, Kuner R, Sültmann H, Provenzano M, ... ... Plass C, et al. BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence. Nature Genetics. 47: 22-30. PMID 25485837 DOI: 10.1038/Ng.3165 |
0.4 |
|
| 2015 |
Schnöder TM, Arreba-Tutusaus P, Griehl I, Bullinger L, Buschbeck M, Lane SW, Döhner K, Plass C, Lipka DB, Heidel FH, Fischer T. Epo-induced erythroid maturation is dependent on Plcγ1 signaling. Cell Death and Differentiation. 22: 974-85. PMID 25394487 DOI: 10.1038/Cdd.2014.186 |
0.382 |
|
| 2015 |
Yang R, Pfütze K, Zucknick M, Sutter C, Wappenschmidt B, Marme F, Qu B, Cuk K, Engel C, Schott S, Schneeweiss A, Brenner H, Claus R, Plass C, Bugert P, et al. DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood. International Journal of Cancer. Journal International Du Cancer. 136: 1845-55. PMID 25213452 DOI: 10.1002/Ijc.29205 |
0.488 |
|
| 2015 |
Fluhr S, Krombholz CF, Meier A, Plass C, Niemeyer C, Flotho C. Epigenetic Changes Accompany Disordered Hemoglobin Regulation in Juvenile Myelomonocytic Leukemia Blood. 126: 438-438. DOI: 10.1182/Blood.V126.23.438.438 |
0.501 |
|
| 2015 |
Drennan S, D'Avola A, Gao Y, Chrysostomou E, Steele AJ, Zenz T, Plass C, Johnson PW, Williams AP, Packham G, Stevenson FK, Oakes CC, Forconi F. IL-10 Production By CLL Cells Is Enhanced in the Anergic IGHV Mutated Subset and Associates with Reduced DNA Methylation of the IL-10 Locus Blood. 126: 2917-2917. DOI: 10.1182/Blood.V126.23.2917.2917 |
0.415 |
|
| 2015 |
Oakes CC, Seifert M, Assenov Y, Gu L, Przekopowitz M, Ruppert AS, Wang Q, Imbusch C, Serva A, Koser S, Brocks D, Lipka DB, Bogatyrova O, Brors B, Weichenhan D, ... ... Plass C, et al. Progressive Epigenetic Programming during B Cell Maturation Is Reflected in a Continuum of Epigenetic Disease Phenotypes in Chronic Lymphocytic Leukemia Blood. 126: 2436-2436. DOI: 10.1182/Blood.V126.23.2436.2436 |
0.463 |
|
| 2015 |
Krombholz CF, Meier A, Aumann K, Fluhr S, Kollek M, Lipka DB, Plass C, Witte T, Niemeyer C, Erlacher M, Flotho C. 5-Azacytidine Reduces Leukemic Burden in a Xenograft Model of Juvenile Myelomonocytic Leukemia Blood. 126: 1655-1655. DOI: 10.1182/Blood.V126.23.1655.1655 |
0.468 |
|
| 2015 |
Oakes CC, Seifert M, Yassen A, Gu L, Przekopowitz M, Ruppert A, Serva A, Koser S, Brocks D, Lipka D, Bogatyrova O, Mertens D, Zapatka M, Lichter P, Doehner H, ... ... Plass C, et al. Abstract B25: Progressive epigenetic programming during B cell maturation yields a continuum of clonal disease phenotypes with distinct etiologies in chronic lymphocytic leukemia. Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Hemmal14-B25 |
0.357 |
|
| 2015 |
Weigel C, Veldwijk MR, Oakes CC, Seibold P, Slynko A, Liesenfeld DB, Herskind C, Sperk E, Benner A, Plass C, Wenz F, Chang-Claude J, Schmezer P, Popanda O. Abstract 3445: Diacylglycerol kinase alpha as a novel epigenetically regulated risk marker for radiotherapy-induced fibrosis Cancer Research. 75: 3445-3445. DOI: 10.1158/1538-7445.Am2015-3445 |
0.486 |
|
| 2015 |
Goeppert B, Ernst C, Baer C, Mehrabi A, Hafezi M, Renner M, Warth A, Stenzinger A, Weichert W, Schirmacher P, Plass C, Weichenhan D. Methylome screen identifies epigenetically deregulated microRNAs in cholangiocarcinoma Zeitschrift FüR Gastroenterologie. 53. DOI: 10.1055/S-0034-1397185 |
0.313 |
|
| 2015 |
Lipka DB, Witte T, Wiesenfarth M, Zucknick M, Konermann C, Gu L, Claus R, Nöllke P, Niemeyer C, Flotho C, Plass C. Genome-wide DNA methylation profiling reveals two prognostically distinct subgroups of juvenile myelomonocytic leukemia Experimental Hematology. 43: S47. DOI: 10.1016/J.Exphem.2015.06.059 |
0.49 |
|
| 2014 |
Lipka DB, Wang Q, Cabezas-Wallscheid N, Klimmeck D, Weichenhan D, Herrmann C, Lier A, Brocks D, von Paleske L, Renders S, Wünsche P, Zeisberger P, Gu L, Haas S, Essers MA, ... ... Plass C, et al. Identification of DNA methylation changes at cis-regulatory elements during early steps of HSC differentiation using tagmentation-based whole genome bisulfite sequencing. Cell Cycle (Georgetown, Tex.). 13: 3476-87. PMID 25483069 DOI: 10.4161/15384101.2014.973334 |
0.499 |
|
| 2014 |
Witte T, Plass C, Gerhauser C. Pan-cancer patterns of DNA methylation. Genome Medicine. 6: 66. PMID 25473433 DOI: 10.1186/S13073-014-0066-6 |
0.517 |
|
| 2014 |
Baude A, Lindroth AM, Plass C. PRC2 loss amplifies Ras signaling in cancer. Nature Genetics. 46: 1154-5. PMID 25352098 DOI: 10.1038/Ng.3124 |
0.371 |
|
| 2014 |
Gaedcke J, Leha A, Claus R, Weichenhan D, Jung K, Kitz J, Grade M, Wolff HA, Jo P, Doyen J, Gérard JP, Johnsen SA, Plass C, Beißbarth T, Ghadimi M. Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancer. Oncotarget. 5: 8123-35. PMID 25261372 DOI: 10.18632/Oncotarget.2347 |
0.421 |
|
| 2014 |
Cabezas-Wallscheid N, Klimmeck D, Hansson J, Lipka DB, Reyes A, Wang Q, Weichenhan D, Lier A, von Paleske L, Renders S, Wünsche P, Zeisberger P, Brocks D, Gu L, Herrmann C, ... ... Plass C, et al. Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis. Cell Stem Cell. 15: 507-22. PMID 25158935 DOI: 10.1016/J.Exphem.2015.06.058 |
0.484 |
|
| 2014 |
Weiss M, Plass C, Gerhauser C. Role of lncRNAs in prostate cancer development and progression. Biological Chemistry. 395: 1275-90. PMID 25153594 DOI: 10.1515/Hsz-2014-0201 |
0.335 |
|
| 2014 |
Poetsch AR, Lipka DB, Witte T, Claus R, Nöllke P, Zucknick M, Olk-Batz C, Fluhr S, Dworzak M, De Moerloose B, Starý J, Zecca M, Hasle H, Schmugge M, van den Heuvel-Eibrink MM, ... ... Plass C, et al. RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia. Epigenetics : Official Journal of the Dna Methylation Society. 9: 1252-60. PMID 25147919 DOI: 10.4161/Epi.29941 |
0.469 |
|
| 2014 |
Arab K, Park YJ, Lindroth AM, Schäfer A, Oakes C, Weichenhan D, Lukanova A, Lundin E, Risch A, Meister M, Dienemann H, Dyckhoff G, Herold-Mende C, Grummt I, Niehrs C, ... Plass C, et al. Long noncoding RNA TARID directs demethylation and activation of the tumor suppressor TCF21 via GADD45A. Molecular Cell. 55: 604-14. PMID 25087872 DOI: 10.1016/J.Molcel.2014.06.031 |
0.373 |
|
| 2014 |
Brocks D, Assenov Y, Minner S, Bogatyrova O, Simon R, Koop C, Oakes C, Zucknick M, Lipka DB, Weischenfeldt J, Feuerbach L, Cowper-Sal Lari R, Lupien M, Brors B, Korbel J, ... ... Plass C, et al. Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer. Cell Reports. 8: 798-806. PMID 25066126 DOI: 10.1016/J.Celrep.2014.06.053 |
0.479 |
|
| 2014 |
Steurer S, Mayer PS, Adam M, Krohn A, Koop C, Ospina-Klinck D, Tehrani AA, Simon R, Tennstedt P, Graefen M, Wittmer C, Brors B, Plass C, Korbel J, Weischenfeldt J, et al. TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer. European Urology. 66: 978-81. PMID 25015038 DOI: 10.1016/J.Eururo.2014.06.027 |
0.312 |
|
| 2014 |
Sonnet M, Claus R, Becker N, Zucknick M, Petersen J, Lipka DB, Oakes CC, Andrulis M, Lier A, Milsom MD, Witte T, Gu L, Kim-Wanner SZ, Schirmacher P, Wulfert M, ... ... Plass C, et al. Early aberrant DNA methylation events in a mouse model of acute myeloid leukemia. Genome Medicine. 6: 34. PMID 24944583 DOI: 10.1186/Gm551 |
0.47 |
|
| 2014 |
Wick W, Weller M, van den Bent M, Sanson M, Weiler M, von Deimling A, Plass C, Hegi M, Platten M, Reifenberger G. MGMT testing--the challenges for biomarker-based glioma treatment. Nature Reviews. Neurology. 10: 372-85. PMID 24912512 DOI: 10.1038/Nrneurol.2014.100 |
0.455 |
|
| 2014 |
Weigel C, Schmezer P, Plass C, Popanda O. Epigenetics in radiation-induced fibrosis. Oncogene. 34: 2145-55. PMID 24909163 DOI: 10.1038/Onc.2014.145 |
0.367 |
|
| 2014 |
Claus R, Lucas DM, Ruppert AS, Williams KE, Weng D, Patterson K, Zucknick M, Oakes CC, Rassenti LZ, Greaves AW, Geyer S, Wierda WG, Brown JR, Gribben JG, Barrientos JC, ... ... Plass C, et al. Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia. Blood. 124: 42-8. PMID 24868078 DOI: 10.1182/Blood-2014-02-555722 |
0.427 |
|
| 2014 |
Warta R, Herold-Mende C, Chaisaingmongkol J, Popanda O, Mock A, Mogler C, Osswald F, Herpel E, Küstner S, Eckstein V, Plass C, Plinkert P, Schmezer P, Dyckhoff G. Reduced promoter methylation and increased expression of CSPG4 negatively influences survival of HNSCC patients. International Journal of Cancer. Journal International Du Cancer. 135: 2727-34. PMID 24740185 DOI: 10.1002/Ijc.28906 |
0.508 |
|
| 2014 |
Song S, Walter V, Karaca M, Li Y, Bartlett CS, Smiraglia DJ, Serber D, Sproul CD, Plass C, Zhang J, Hayes DN, Zheng Y, Weissman BE. Gene silencing associated with SWI/SNF complex loss during NSCLC development. Molecular Cancer Research : McR. 12: 560-70. PMID 24445599 DOI: 10.1158/1541-7786.Mcr-13-0427 |
0.468 |
|
| 2014 |
Marcucci G, Yan P, Maharry K, Frankhouser D, Nicolet D, Metzeler KH, Kohlschmidt J, Mrózek K, Wu YZ, Bucci D, Curfman JP, Whitman SP, Eisfeld AK, Mendler JH, Schwind S, ... ... Plass C, et al. Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene score. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 548-56. PMID 24378410 DOI: 10.1200/Jco.2013.50.6337 |
0.453 |
|
| 2014 |
Oakes CC, Claus R, Gu L, Assenov Y, Hüllein J, Zucknick M, Bieg M, Brocks D, Bogatyrova O, Schmidt CR, Rassenti L, Kipps TJ, Mertens D, Lichter P, Döhner H, ... ... Plass C, et al. Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia. Cancer Discovery. 4: 348-61. PMID 24356097 DOI: 10.1158/2159-8290.Cd-13-0349 |
0.478 |
|
| 2014 |
Kuhmann C, Li C, Kloor M, Salou M, Weigel C, Schmidt CR, Ng LW, Tsui WW, Leung SY, Yuen ST, Becker N, Weichenhan D, Plass C, Schmezer P, Chan TL, et al. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer. Human Molecular Genetics. 23: 2043-54. PMID 24282031 DOI: 10.1093/Hmg/Ddt599 |
0.564 |
|
| 2014 |
Goeppert B, Konermann C, Schmidt CR, Bogatyrova O, Geiselhart L, Ernst C, Gu L, Becker N, Zucknick M, Mehrabi A, Hafezi M, Klauschen F, Stenzinger A, Warth A, Breuhahn K, ... ... Plass C, et al. Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway. Hepatology (Baltimore, Md.). 59: 544-54. PMID 24002901 DOI: 10.1002/Hep.26721 |
0.54 |
|
| 2014 |
Dutruel C, Bergmann F, Rooman I, Zucknick M, Weichenhan D, Geiselhart L, Kaffenberger T, Rachakonda PS, Bauer A, Giese N, Hong C, Xie H, Costello JF, Hoheisel J, Kumar R, ... ... Plass C, et al. Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development. Oncogene. 33: 3401-10. PMID 23912455 DOI: 10.1038/Onc.2013.312 |
0.479 |
|
| 2014 |
Wolf C, Filarsky K, Garding A, Claus R, Oakes CC, Idler I, Plass C, Lichter P, Doehner H, Stilgenbauer S, Mertens D. NFATc1 Is Transcriptionally Activated in Chronic Lymphocytic Leukemia (CLL) By Promotor DNA-Hypomethylation Which Correlates with in-Vitro Vulnerability to Calcineurin Inhibitors Blood. 124: 1941-1941. DOI: 10.1182/Blood.V124.21.1941.1941 |
0.469 |
|
| 2014 |
Bender S, Tang Y, Lindroth AM, Hovestadt V, Zapatka M, Jones DTW, Kool M, Northcott PA, Sturm D, Lichter P, Plass C, Cho Y. Abstract 3084: Epigenetic deregulation in H3.3-K27M mutant pediatric high-grade gliomas Cancer Research. 74: 3084-3084. DOI: 10.1158/1538-7445.Am2014-3084 |
0.48 |
|
| 2014 |
Hoffmann CM, Giessler KM, Ball CR, Dubash TD, Dieter SM, Bergmann S, Weichert W, Kalle CV, Schneider M, Baer C, Plass C, Schmidt M, Glimm H. Abstract 3043: Mesenchymal phenoptype of metastasizing primary human colorectal TIC is maintained through epigenetic silencing of miR-200 Cancer Research. 74: 3043-3043. DOI: 10.1158/1538-7445.Am2014-3043 |
0.367 |
|
| 2014 |
Baer C, Plass C. Aberrant DNA Methylation Reference Module in Biomedical Research. DOI: 10.1016/B978-0-12-801238-3.00008-8 |
0.369 |
|
| 2013 |
McGraw S, Oakes CC, Martel J, Cirio MC, de Zeeuw P, Mak W, Plass C, Bartolomei MS, Chaillet JR, Trasler JM. Loss of DNMT1o disrupts imprinted X chromosome inactivation and accentuates placental defects in females. Plos Genetics. 9: e1003873. PMID 24278026 DOI: 10.1371/Journal.Pgen.1003873 |
0.418 |
|
| 2013 |
Lindroth AM, Plass C. Recurrent H3.3 alterations in childhood tumors. Nature Genetics. 45: 1413-4. PMID 24270444 DOI: 10.1038/Ng.2832 |
0.371 |
|
| 2013 |
Banzhaf-Strathmann J, Claus R, Mücke O, Rentzsch K, van der Zee J, Engelborghs S, De Deyn PP, Cruts M, van Broeckhoven C, Plass C, Edbauer D. Promoter DNA methylation regulates progranulin expression and is altered in FTLD. Acta Neuropathologica Communications. 1: 16. PMID 24252647 DOI: 10.1186/2051-5960-1-16 |
0.407 |
|
| 2013 |
Bender S, Tang Y, Lindroth AM, Hovestadt V, Jones DT, Kool M, Zapatka M, Northcott PA, Sturm D, Wang W, Radlwimmer B, Højfeldt JW, Truffaux N, Castel D, Schubert S, ... ... Plass C, et al. Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Cancer Cell. 24: 660-72. PMID 24183680 DOI: 10.1016/J.Ccr.2013.10.006 |
0.428 |
|
| 2013 |
Jäger N, Schlesner M, Jones DT, Raffel S, Mallm JP, Junge KM, Weichenhan D, Bauer T, Ishaque N, Kool M, Northcott PA, Korshunov A, Drews RM, Koster J, Versteeg R, ... ... Plass C, et al. Hypermutation of the inactive X chromosome is a frequent event in cancer. Cell. 155: 567-81. PMID 24139898 DOI: 10.1016/J.Cell.2013.09.042 |
0.374 |
|
| 2013 |
Plass C, Pfister SM, Lindroth AM, Bogatyrova O, Claus R, Lichter P. Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nature Reviews. Genetics. 14: 765-80. PMID 24105274 DOI: 10.1038/Nrg3554 |
0.517 |
|
| 2013 |
Wang Q, Gu L, Adey A, Radlwimmer B, Wang W, Hovestadt V, Bähr M, Wolf S, Shendure J, Eils R, Plass C, Weichenhan D. Tagmentation-based whole-genome bisulfite sequencing. Nature Protocols. 8: 2022-32. PMID 24071908 DOI: 10.1038/Nprot.2013.118 |
0.341 |
|
| 2013 |
Goeppert B, Schmidt CR, Geiselhart L, Dutruel C, Capper D, Renner M, Vogel MN, Zachskorn C, Zinke J, Campos B, Schmezer P, Popanda O, Wick W, Weller M, Meyermann R, ... ... Plass C, et al. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation. Journal of Neuropathology and Experimental Neurology. 72: 933-41. PMID 24042196 DOI: 10.1097/Nen.0B013E3182A59A88 |
0.42 |
|
| 2013 |
Weichenhan D, Plass C. The evolving epigenome. Human Molecular Genetics. 22: R1-6. PMID 23900077 DOI: 10.1093/Hmg/Ddt348 |
0.489 |
|
| 2013 |
Tönjes M, Barbus S, Park YJ, Wang W, Schlotter M, Lindroth AM, Pleier SV, Bai AH, Karra D, Piro RM, Felsberg J, Addington A, Lemke D, Weibrecht I, Hovestadt V, ... ... Plass C, et al. BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1. Nature Medicine. 19: 901-8. PMID 23793099 DOI: 10.1038/Nm.3217 |
0.382 |
|
| 2013 |
Tsourlakis MC, Schoop M, Plass C, Huland H, Graefen M, Steuber T, Schlomm T, Simon R, Sauter G, Sirma H, Minner S. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence. Human Pathology. 44: 1789-96. PMID 23642739 DOI: 10.1016/J.Humpath.2013.01.022 |
0.338 |
|
| 2013 |
Kostareli E, Holzinger D, Bogatyrova O, Hielscher T, Wichmann G, Keck M, Lahrmann B, Grabe N, Flechtenmacher C, Schmidt CR, Seiwert T, Dyckhoff G, Dietz A, Höfler D, Pawlita M, ... ... Plass C, et al. HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas. The Journal of Clinical Investigation. 123: 2488-501. PMID 23635773 DOI: 10.1172/Jci67010 |
0.388 |
|
| 2013 |
Wiestler B, Claus R, Hartlieb SA, Schliesser MG, Weiss EK, Hielscher T, Platten M, Dittmann LM, Meisner C, Felsberg J, Happold C, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, ... ... Plass C, et al. Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective. Neuro-Oncology. 15: 1017-26. PMID 23595628 DOI: 10.1093/Neuonc/Not043 |
0.42 |
|
| 2013 |
Garding A, Bhattacharya N, Claus R, Ruppel M, Tschuch C, Filarsky K, Idler I, Zucknick M, Caudron-Herger M, Oakes C, Fleig V, Keklikoglou I, Allegra D, Serra L, Thakurela S, ... ... Plass C, et al. Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB. Plos Genetics. 9: e1003373. PMID 23593011 DOI: 10.1371/Journal.Pgen.1003373 |
0.444 |
|
| 2013 |
Hsu SH, Motiwala T, Roy S, Claus R, Mustafa M, Plass C, Freitas MA, Ghoshal K, Jacob ST. Methylation of the PTPRO gene in human hepatocellular carcinoma and identification of VCP as its substrate. Journal of Cellular Biochemistry. 114: 1810-8. PMID 23533167 DOI: 10.1002/Jcb.24525 |
0.417 |
|
| 2013 |
Weischenfeldt J, Simon R, Feuerbach L, Schlangen K, Weichenhan D, Minner S, Wuttig D, Warnatz HJ, Stehr H, Rausch T, Jäger N, Gu L, Bogatyrova O, Stütz AM, Claus R, ... ... Plass C, et al. Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. Cancer Cell. 23: 159-70. PMID 23410972 DOI: 10.1016/J.Ccr.2013.01.002 |
0.321 |
|
| 2013 |
Wei QX, Claus R, Hielscher T, Mertens D, Raval A, Oakes CC, Tanner SM, de la Chapelle A, Byrd JC, Stilgenbauer S, Plass C. Germline allele-specific expression of DAPK1 in chronic lymphocytic leukemia. Plos One. 8: e55261. PMID 23383130 DOI: 10.1371/Journal.Pone.0055261 |
0.489 |
|
| 2013 |
Kluth M, Hesse J, Heinl A, Krohn A, Steurer S, Sirma H, Simon R, Mayer PS, Schumacher U, Grupp K, Izbicki JR, Pantel K, Dikomey E, Korbel JO, Plass C, et al. Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 975-83. PMID 23370768 DOI: 10.1038/Modpathol.2012.236 |
0.355 |
|
| 2013 |
Haas J, Frese KS, Park YJ, Keller A, Vogel B, Lindroth AM, Weichenhan D, Franke J, Fischer S, Bauer A, Marquart S, Sedaghat-Hamedani F, Kayvanpour E, Köhler D, Wolf NM, ... ... Plass C, et al. Alterations in cardiac DNA methylation in human dilated cardiomyopathy. Embo Molecular Medicine. 5: 413-29. PMID 23341106 DOI: 10.1002/Emmm.201201553 |
0.47 |
|
| 2013 |
Baer C, Claus R, Plass C. Genome-wide epigenetic regulation of miRNAs in cancer. Cancer Research. 73: 473-7. PMID 23316035 DOI: 10.1158/0008-5472.Can-12-3731 |
0.337 |
|
| 2013 |
Sonnet M, Baer C, Rehli M, Weichenhan D, Plass C. Enrichment of methylated DNA by methyl-CpG immunoprecipitation. Methods in Molecular Biology (Clifton, N.J.). 971: 201-12. PMID 23296965 DOI: 10.1007/978-1-62703-269-8_11 |
0.515 |
|
| 2013 |
Park JY, Kim D, Yang M, Park HY, Lee SH, Rincon M, Kreahling J, Plass C, Smiraglia DJ, Tockman MS, Kim SJ. Gene silencing of SLC5A8 identified by genome-wide methylation profiling in lung cancer. Lung Cancer (Amsterdam, Netherlands). 79: 198-204. PMID 23273563 DOI: 10.1016/J.Lungcan.2012.11.019 |
0.51 |
|
| 2013 |
Faber K, Bullinger L, Ragu C, Garding A, Mertens D, Miller C, Martin D, Walcher D, Döhner K, Döhner H, Claus R, Plass C, Sykes SM, Lane SW, Scholl C, et al. CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling. The Journal of Clinical Investigation. 123: 299-314. PMID 23202735 DOI: 10.1172/Jci64745 |
0.413 |
|
| 2013 |
Claus R, Pfeifer D, Almstedt M, Zucknick M, Hackanson B, Plass C, Lübbert M. Decitabine induces very early in vivo DNA methylation changes in blasts from patients with acute myeloid leukemia. Leukemia Research. 37: 190-6. PMID 23158571 DOI: 10.1016/J.Leukres.2012.10.015 |
0.474 |
|
| 2013 |
Scherf DB, Sarkisyan N, Jacobsson H, Claus R, Bermejo JL, Peil B, Gu L, Muley T, Meister M, Dienemann H, Plass C, Risch A. Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4. Oncogene. 32: 3329-38. PMID 22945651 DOI: 10.1038/Onc.2012.344 |
0.517 |
|
| 2013 |
Popanda O, Seibold P, Nikolov I, Oakes CC, Burwinkel B, Hausmann S, Flesch-Janys D, Plass C, Chang-Claude J, Schmezer P. Germline variants of base excision repair genes and breast cancer: A polymorphism in DNA polymerase gamma modifies gene expression and breast cancer risk. International Journal of Cancer. 132: 55-62. PMID 22684821 DOI: 10.1002/Ijc.27665 |
0.32 |
|
| 2013 |
Schmutz M, Zucknick M, Schlenk RF, Döhner K, Döhner H, Plass C, Bullinger L. Differential DNA Methylation Predicts Response To Combined Treatment Regimens With a DNA Methyltransferase Inhibitor In Acute Myeloid Leukemia (AML) Blood. 122: 2539-2539. DOI: 10.1182/Blood.V122.21.2539.2539 |
0.516 |
|
| 2013 |
Oakes CC, Claus R, Gu L, Assenov Y, Hüllein J, Zucknick M, Brocks D, Bogatyrova O, Schmidt CR, Rassenti L, Kipps TJ, Mertens D, Lichter P, Döhner H, Stilgenbauer S, ... ... Plass C, et al. Heterogeneity and Evolution Of DNA Methylation In Chronic Lymphocytic Leukemia Blood. 122: 1626-1626. DOI: 10.1182/Blood.V122.21.1626.1626 |
0.517 |
|
| 2013 |
Schnoeder TM, Arreba-Tutusaus P, Griehl I, Bullinger L, Doehner K, Plass C, Lipka DB, Heidel FH, Fischer T. Epo-Induced Erythroid Maturation Is Dependent On Plcγ1 Signalling Blood. 122: 1182-1182. DOI: 10.1182/Blood.V122.21.1182.1182 |
0.435 |
|
| 2013 |
Gaedcke J, Claus R, Leha A, Grade M, Beißbart T, Ghadimi M, Weichenhahn D, Plass C. Abstract 75: CpG methylation signature to predict outcome in preoperatively treated rectal cancer. Cancer Research. 73: 75-75. DOI: 10.1158/1538-7445.Am2013-75 |
0.47 |
|
| 2013 |
Huang PJ, Göring W, Hielscher T, Weichenhan D, Schulz WA, Plass C, Gerhäuser C. Abstract 2: Genome-wide DNA methylation profiling identifies novel diagnostic and prognostic biomarkers in early stage prostate cancer. Cancer Research. 73: 2-2. DOI: 10.1158/1538-7445.Am2013-2 |
0.487 |
|
| 2013 |
Fluhr S, Witte T, Krombholz C, Plass C, Niemeyer C, Flotho C. Prognostic relevance of disordered epigenetic regulation in juvenile myelomonocytic leukemia Klinische PäDiatrie. 225. DOI: 10.1055/S-0033-1343633 |
0.317 |
|
| 2013 |
Goeppert B, Konermann C, Schmid C, Bogatyrova O, Geiselhart L, Weichenhahn D, Becker N, Mehrabi A, Hafezi M, Klauschen F, Stenzinger A, Renner M, Warth A, Gu L, Zucknick M, ... ... Plass C, et al. Global alterations of DNA methylation patterns in cholangiocarcinoma target cancer relevant pathways including Wnt/β-catenin signaling Zeitschrift Fur Gastroenterologie. 51. DOI: 10.1055/S-0032-1332045 |
0.402 |
|
| 2012 |
Sturm D, Witt H, Hovestadt V, Khuong-Quang DA, Jones DT, Konermann C, Pfaff E, Tönjes M, Sill M, Bender S, Kool M, Zapatka M, Becker N, Zucknick M, Hielscher T, ... ... Plass C, et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell. 22: 425-37. PMID 23079654 DOI: 10.1016/J.Ccr.2012.08.024 |
0.373 |
|
| 2012 |
Faryna M, Konermann C, Aulmann S, Bermejo JL, Brugger M, Diederichs S, Rom J, Weichenhan D, Claus R, Rehli M, Schirmacher P, Sinn HP, Plass C, Gerhauser C. Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 4937-50. PMID 22930747 DOI: 10.1096/Fj.12-209502 |
0.508 |
|
| 2012 |
Börno ST, Fischer A, Kerick M, Fälth M, Laible M, Brase JC, Kuner R, Dahl A, Grimm C, Sayanjali B, Isau M, Röhr C, Wunderlich A, Timmermann B, Claus R, ... Plass C, et al. Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylation. Cancer Discovery. 2: 1024-35. PMID 22930729 DOI: 10.1158/2159-8290.Cd-12-0041 |
0.483 |
|
| 2012 |
Baer C, Claus R, Frenzel LP, Zucknick M, Park YJ, Gu L, Weichenhan D, Fischer M, Pallasch CP, Herpel E, Rehli M, Byrd JC, Wendtner CM, Plass C. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia. Cancer Research. 72: 3775-85. PMID 22710432 DOI: 10.1158/0008-5472.Can-12-0803 |
0.426 |
|
| 2012 |
Krohn A, Diedler T, Burkhardt L, Mayer PS, De Silva C, Meyer-Kornblum M, Kötschau D, Tennstedt P, Huang J, Gerhäuser C, Mader M, Kurtz S, Sirma H, Saad F, Steuber T, ... ... Plass C, et al. Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer. The American Journal of Pathology. 181: 401-12. PMID 22705054 DOI: 10.1016/J.Ajpath.2012.04.026 |
0.371 |
|
| 2012 |
Claus R, Wilop S, Hielscher T, Sonnet M, Dahl E, Galm O, Jost E, Plass C. A systematic comparison of quantitative high-resolution DNA methylation analysis and methylation-specific PCR. Epigenetics. 7: 772-80. PMID 22647397 DOI: 10.4161/Epi.20299 |
0.513 |
|
| 2012 |
Claus R, Lucas DM, Stilgenbauer S, Ruppert AS, Yu L, Zucknick M, Mertens D, Bühler A, Oakes CC, Larson RA, Kay NE, Jelinek DF, Kipps TJ, Rassenti LZ, Gribben JG, ... ... Plass C, et al. Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 2483-91. PMID 22564988 DOI: 10.1200/Jco.2011.39.3090 |
0.454 |
|
| 2012 |
Grønbæk K, Müller-Tidow C, Perini G, Lehmann S, Bach Treppendahl M, Mills K, Plass C, Schlegelberger B. A critical appraisal of tools available for monitoring epigenetic changes in clinical samples from patients with myeloid malignancies. Haematologica. 97: 1380-8. PMID 22491733 DOI: 10.3324/Haematol.2011.058305 |
0.386 |
|
| 2012 |
Chaisaingmongkol J, Popanda O, Warta R, Dyckhoff G, Herpel E, Geiselhart L, Claus R, Lasitschka F, Campos B, Oakes CC, Bermejo JL, Herold-Mende C, Plass C, Schmezer P. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma. Oncogene. 31: 5108-16. PMID 22286769 DOI: 10.1038/Onc.2011.660 |
0.57 |
|
| 2012 |
Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DA, Tönjes M, Hovestadt V, Albrecht S, Kool M, Nantel A, Konermann C, ... ... Plass C, et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature. 482: 226-31. PMID 22286061 DOI: 10.1038/Nature10833 |
0.364 |
|
| 2012 |
Campos B, Warta R, Chaisaingmongkol J, Geiselhart L, Popanda O, Hartmann C, von Deimling A, Unterberg A, Plass C, Schmezer P, Herold-Mende C. Epigenetically mediated downregulation of the differentiation-promoting chaperon protein CRABP2 in astrocytic gliomas. International Journal of Cancer. Journal International Du Cancer. 131: 1963-8. PMID 22275178 DOI: 10.1002/Ijc.27446 |
0.473 |
|
| 2012 |
Claus R, Hackanson B, Poetsch AR, Zucknick M, Sonnet M, Blagitko-Dorfs N, Hiller J, Wilop S, Brümmendorf TH, Galm O, Platzbecker U, Byrd JC, Döhner K, Döhner H, Lübbert M, ... Plass C, et al. Quantitative analyses of DAPK1 methylation in AML and MDS. International Journal of Cancer. Journal International Du Cancer. 131: E138-42. PMID 21918973 DOI: 10.1002/Ijc.26429 |
0.504 |
|
| 2012 |
Schulz A, Park YJ, Claus R, Kashkar H, Seeger J, Claasen J, Pallasch CP, Plass C, Hallek M, Wendtner C, Frenzel LP. TOSO Deficiency Exerts Impact On BAFF-R Expression, Thereby Causing Impaired B Cell Development in Vivo Blood. 120: 3898-3898. DOI: 10.1182/Blood.V120.21.3898.3898 |
0.363 |
|
| 2012 |
Claus R, Ruppert AS, Lucas DM, Zucknick M, Rassenti LZ, Greaves A, Neuberg DS, Wierda WG, Keating MJ, Brown JR, Gribben JG, Rai KR, Grever MR, Kay NE, Kipps TJ, ... Plass C, et al. The Relative Significance of ZAP -70 Promoter Methylation As a Prognostic Factor in Previously Untreated Chronic Lymphocytic Leukemia: Validation of Results Using a Second Large CLL Research Consortium (CRC) Patient Data Set Blood. 120: 3865-3865. DOI: 10.1182/Blood.V120.21.3865.3865 |
0.492 |
|
| 2012 |
Vegi NM, Klappacher J, Oswald F, Claus R, Mulaw MM, Thiel V, Rawat VP, Fend LQ, Plass C, Döhner K, Döhner H, Hiddemann W, Buske MF, Buske C. AML1-ETO Collaborates with the TALE Homeobox Genes MEIS1 and MEIS2 in Inducing AML. Blood. 120: 2387-2387. DOI: 10.1182/Blood.V120.21.2387.2387 |
0.377 |
|
| 2012 |
Hertlein EK, Chen TL, Claus R, Plass C, Lehman A, Jarjoura D, Maddocks K, Jones JA, Lucas DM, Johnson AJ, Byrd JC. The Hsp90 Inhibitor 17-DMAG Increases SOCS3 and Regulates Cytokine Production, Migration and Cell Death in Chronic Lymphocytic Leukemia Blood. 120: 1362-1362. DOI: 10.1182/Blood.V120.21.1362.1362 |
0.4 |
|
| 2012 |
Motiwala T, Roy S, Liu S, Schwind S, Claus R, Mo X, Garzon R, Dohner H, Dohner K, Jarjoura D, Plass C, Marcucci G, Jacob ST. Aberrant Epigenetic Suppression of the Ptprot Gene Encoding a Protein Tyrosine Phosphatase Targeting KIT in Acute Myeloid Leukemia Blood. 120: 1322-1322. DOI: 10.1182/Blood.V120.21.1322.1322 |
0.384 |
|
| 2012 |
Baer C, Rehli M, Byrd JC, Wendtner C, Plass C, Claus R, Frenzel L, Zucknick M, Park YJ, Gu L, Weichenhan D, Fischer M, Pallasch C. Abstract B10: Genome-wide profiling reveals hyper- and hypomethylation at microRNA promoters in chronic lymphocytic leukemia Cancer Research. 72: B10-B10. DOI: 10.1158/1538-7445.Nonrna12-B10 |
0.425 |
|
| 2012 |
Krohn A, Stahl P, Burkhardt L, Gerhäuser C, Huang J, Mader M, Sirma H, Plass C, Sauter G, Minner S, Simon R, Schlomm T. Abstract 4854: Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion positive and fusion negative prostate cancer Cancer Research. 72: 4854-4854. DOI: 10.1158/1538-7445.Am2012-4854 |
0.376 |
|
| 2012 |
Schmezer P, Chaisaingmongkol J, Warta R, Dyckhoff G, Oakes CC, Kuhmann C, Geiselhart L, Waas P, Herold-Mende C, Plass C, Popanda O. Abstract 4032: Consequences ofNEIL1promoter hypermethylation in head and neck squamous cell carcinoma Cancer Research. 72: 4032-4032. DOI: 10.1158/1538-7445.Am2012-4032 |
0.49 |
|
| 2012 |
Sturm D, Witt H, Jacob K, Konermann C, Jones DT, Pfaff E, Korshunov A, Rizhova M, Hovestadt V, Remke M, Meter Tv, Frühwald M, Kramm C, Kulozik AE, Deimling Av, ... ... Plass C, et al. Abstract 3687: An integrative genomics approach identifies distinct molecular and epigenetic subgroups of pediatric glioblastoma Cancer Research. 72: 3687-3687. DOI: 10.1158/1538-7445.Am2012-3687 |
0.461 |
|
| 2012 |
Schmidt CR, Oakes CC, Boutros M, Plass C. Abstract 2180: Identification of nuclear transcription factor Y (NF-Y) as a novel key transcriptional regulator of the tumor-suppressor geneDAPK1 Cancer Research. 72: 2180-2180. DOI: 10.1158/1538-7445.Am2012-2180 |
0.403 |
|
| 2012 |
Schwartzentruber J, Korshunov A, Liu X, Jones DTW, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DK, Tönjes M, Hovestadt V, Albrecht S, Kool M, Nantel A, Konermann C, ... ... Plass C, et al. Erratum: Corrigendum: Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma Nature. 484: 130-130. DOI: 10.1038/Nature11026 |
0.359 |
|
| 2012 |
Popanda O, Kuhmann C, Schmezer P, Li C, Wing L, Leung S, Kloor M, Weichenhan D, Plass C, Chan T. 529 Promoter Methylation of the Ligase IV Gene in Human Colorectal Cancer European Journal of Cancer. 48: S125-S126. DOI: 10.1016/S0959-8049(12)71189-9 |
0.468 |
|
| 2012 |
Schlomm T, Burkhardt L, Stahl P, Gerhäuser C, Mader M, Sirma H, Plass C, Sauter G, Simon R, Minner S. 323 Genomic Deletion Of Pten Is Associated With Tumor Progression And Early Psa Recurrence In Erg Fusion Positive And Fusion Negative Prostate Cancer The Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.383 |
0.314 |
|
| 2011 |
Huang PH, Plass C, Chen CS. Effects of Histone Deacetylase Inhibitors on Modulating H3K4 Methylation Marks - A Novel Cross-Talk Mechanism between Histone-Modifying Enzymes. Molecular and Cellular Pharmacology. 3: 39-43. PMID 22468166 DOI: 10.4255/Mcpharmacol.11.06 |
0.456 |
|
| 2011 |
Arab K, Smith LT, Gast A, Weichenhan D, Huang JP, Claus R, Hielscher T, Espinosa AV, Ringel MD, Morrison CD, Schadendorf D, Kumar R, Plass C. Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma. Carcinogenesis. 32: 1467-73. PMID 21771727 DOI: 10.1093/Carcin/Bgr138 |
0.493 |
|
| 2011 |
Kuhmann C, Weichenhan D, Rehli M, Plass C, Schmezer P, Popanda O. DNA methylation changes in cells regrowing after fractioned ionizing radiation. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 101: 116-21. PMID 21704414 DOI: 10.1016/J.Radonc.2011.05.048 |
0.356 |
|
| 2011 |
Tada Y, Yokomizo A, Shiota M, Tsunoda T, Plass C, Naito S. Aberrant DNA methylation of T-cell leukemia, homeobox 3 modulates cisplatin sensitivity in bladder cancer. International Journal of Oncology. 39: 727-33. PMID 21617853 DOI: 10.3892/Ijo.2011.1049 |
0.442 |
|
| 2011 |
Freedman ML, Monteiro AN, Gayther SA, Coetzee GA, Risch A, Plass C, Casey G, De Biasi M, Carlson C, Duggan D, James M, Liu P, Tichelaar JW, Vikis HG, You M, et al. Principles for the post-GWAS functional characterization of cancer risk loci. Nature Genetics. 43: 513-8. PMID 21614091 DOI: 10.1038/Ng.840 |
0.386 |
|
| 2011 |
Poetsch AR, Plass C. Transcriptional regulation by DNA methylation. Cancer Treatment Reviews. 37: S8-12. PMID 21601364 DOI: 10.1016/J.Ctrv.2011.04.010 |
0.483 |
|
| 2011 |
Krais AM, Park YJ, Plass C, Schmeiser HH. Determination of genomic 5-hydroxymethyl-2'-deoxycytidine in human DNA by capillary electrophoresis with laser induced fluorescence. Epigenetics. 6: 560-5. PMID 21593596 DOI: 10.4161/Epi.6.5.15678 |
0.401 |
|
| 2011 |
Olk-Batz C, Poetsch AR, Nöllke P, Claus R, Zucknick M, Sandrock I, Witte T, Strahm B, Hasle H, Zecca M, Stary J, Bergstraesser E, De Moerloose B, Trebo M, van den Heuvel-Eibrink MM, ... ... Plass C, et al. Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome. Blood. 117: 4871-80. PMID 21406719 DOI: 10.1182/Blood-2010-08-298968 |
0.505 |
|
| 2011 |
Huang J, Plass C, Gerhauser C. Cancer chemoprevention by targeting the epigenome. Current Drug Targets. 12: 1925-56. PMID 21158707 DOI: 10.2174/138945011798184155 |
0.503 |
|
| 2011 |
Park YJ, Claus R, Weichenhan D, Plass C. Genome-wide epigenetic modifications in cancer. Progress in Drug Research. Fortschritte Der Arzneimittelforschung. ProgrèS Des Recherches Pharmaceutiques. 67: 25-49. PMID 21141723 DOI: 10.1007/978-3-7643-8989-5_2 |
0.518 |
|
| 2011 |
Chen SS, Claus R, Lucas DM, Yu L, Qian J, Ruppert AS, West DA, Williams KE, Johnson AJ, Sablitzky F, Plass C, Byrd JC. Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL. Blood. 117: 862-71. PMID 21098398 DOI: 10.1182/Blood-2010-05-284638 |
0.509 |
|
| 2011 |
Frenzel LP, Claus R, Plume N, Schwamb J, Konermann C, Pallasch CP, Claasen J, Brinker R, Wollnik B, Plass C, Wendtner CM. Sustained NF-kappaB activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 (A20) locus. International Journal of Cancer. Journal International Du Cancer. 128: 2495-500. PMID 20669229 DOI: 10.1002/Ijc.25579 |
0.433 |
|
| 2011 |
Oakes CC, Claus R, Schmidt C, Park YJ, Boutros M, Stilgenbauer S, Plass C. Reduced c-FOS Is Associated with Poor Prognosis and Clinical Course in Chronic Lymphocytic Leukemia Blood. 118: 2433-2433. DOI: 10.1182/Blood.V118.21.2433.2433 |
0.364 |
|
| 2011 |
Poetsch AR, Claus R, Bonnet J, Devys D, Rücker FG, Tora L, Döhner K, Döhner H, Plass C. Genetic and Epigenetic Profiling on 7q22 Identifies ATXN7L1 As Candidate Tumor Suppressor in Acute Myelogenous Leukemia Blood. 118: 1408-1408. DOI: 10.1182/Blood.V118.21.1408.1408 |
0.513 |
|
| 2011 |
Claus R, Pfeifer D, Almstedt M, Hackanson B, Zucknick M, Plass C, Lübbert M. Decitabine (DAC) Treatment Induces Very Early In Vivo DNA Methylation and Transcriptome Changes in Primary AML Peripheral Blood Blasts Blood. 118: 1360-1360. DOI: 10.1182/Blood.V118.21.1360.1360 |
0.47 |
|
| 2011 |
Faber K, Bullinger L, Garding A, Mertens D, Martin D, Walcher D, Döhner K, Döhner H, Sykes SM, Claus R, Plass C, Lane SW, Scholl C, Fröhling S. Myeloid Leukemogenesis Driven by Aberrant CDX2 Expression Involves Transcriptional Repression of KLF4 and Deregulated PPARγ Signaling Blood. 118: 1355-1355. DOI: 10.1182/Blood.V118.21.1355.1355 |
0.465 |
|
| 2011 |
Risch A, Schert D, Sarkisyan N, Hagmann W, Bermejo JL, Muley T, Meister M, Dienemann H, Thomas M, Plass C. 1039 POSTER Epigenetic Alterations in Lung Cancer Susceptibility Regions European Journal of Cancer. 47: S107. DOI: 10.1016/S0959-8049(11)70682-7 |
0.347 |
|
| 2010 |
Goeppert B, Schmezer P, Dutruel C, Oakes C, Renner M, Breinig M, Warth A, Vogel MN, Mittelbronn M, Mehrabi A, Gdynia G, Penzel R, Longerich T, Breuhahn K, Popanda O, ... Plass C, et al. Down-regulation of tumor suppressor a kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms Hepatology. 52: 2023-2033. PMID 20979053 DOI: 10.1002/Hep.23939 |
0.387 |
|
| 2010 |
Claus R, Plass C, Armstrong SA, Bullinger L. DNA methylation profiling in acute myeloid leukemia: from recent technological advances to biological and clinical insights. Future Oncology (London, England). 6: 1415-31. PMID 20919827 DOI: 10.2217/Fon.10.110 |
0.459 |
|
| 2010 |
Ghosh S, Yates AJ, Frühwald MC, Miecznikowski JC, Plass C, Smiraglia D. Tissue specific DNA methylation of CpG islands in normal human adult somatic tissues distinguishes neural from non-neural tissues. Epigenetics : Official Journal of the Dna Methylation Society. 5: 527-38. PMID 20505344 DOI: 10.4161/Epi.5.6.12228 |
0.362 |
|
| 2010 |
Blum KA, Liu Z, Lucas DM, Chen P, Xie Z, Baiocchi R, Benson DM, Devine SM, Jones J, Andritsos L, Flynn J, Plass C, Marcucci G, Chan KK, Grever MR, et al. Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation. British Journal of Haematology. 150: 189-95. PMID 20456354 DOI: 10.1111/J.1365-2141.2010.08213.X |
0.396 |
|
| 2010 |
Ghoshal K, Motiwala T, Claus R, Yan P, Kutay H, Datta J, Majumder S, Bai S, Majumder A, Huang T, Plass C, Jacob ST. HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors. Plos One. 5: e10338. PMID 20454457 DOI: 10.1371/Journal.Pone.0010338 |
0.492 |
|
| 2010 |
Fernandez SV, Snider KE, Wu YZ, Russo IH, Plass C, Russo J. DNA methylation changes in a human cell model of breast cancer progression. Mutation Research. 688: 28-35. PMID 20193695 DOI: 10.1016/j.mrfmmm.2010.02.007 |
0.419 |
|
| 2010 |
Frenzel LP, Schulz A, Pallasch CP, Claus R, Ponader S, Burger JA, Hallek M, Plass C, Wendtner C. Microenvironment Influences Expression of TOSO – a Novel NF-Kappa B Target Gene In Chronic Lymphocytic Leukemia Blood. 116: 695-695. DOI: 10.1182/Blood.V116.21.695.695 |
0.386 |
|
| 2010 |
Poetsch AR, Claus R, Bullinger L, Witte T, Lübbert M, Rehli M, Döhner K, Plass C. Genetic and Epigenetic Silencing of Mesoderm Specific Transcript (MEST) In Acute Myelogenous Leukemia. Blood. 116: 3639-3639. DOI: 10.1182/Blood.V116.21.3639.3639 |
0.497 |
|
| 2010 |
Frenzel LP, Schwamb J, Claus R, Claasen J, Brinker R, Pallasch CP, Plass C, Wendtner C. Sustained NF-Kappa B Activity In Chronic Lymphocytic Leukemia Is Independent of Genetic and Epigenetic Modifications of the Tumor Suppressor Genes CYLD and A20 Blood. 116: 3597-3597. DOI: 10.1182/Blood.V116.21.3597.3597 |
0.401 |
|
| 2010 |
Ward A, Petersson J, Konermann C, Faryna M, Strathmann J, Claus R, Weichenhan D, Plass C, Gerhauser C. Abstract B49: Epigenetic changes during disease progression in a murine model of human breast cancer Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-B49 |
0.5 |
|
| 2010 |
Strathmann J, Peterssen J, Claus R, Knapp‐Mohammedy M, Plass C, Gerhauser C. Abstract B48: Xanthohumol from hops (Humulus lupulus L.) reactivates epigentically silenced genes by potential DNA methyltransferase inhibition Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-B48 |
0.48 |
|
| 2010 |
Scherf DB, Sarkisyan NF, Jacobsson HT, Claus R, Bermejo JL, Muley T, Meister M, Dienemann H, Plass C, Risch A. Abstract 4946: The nicotinic acetylcholine receptor genes CHRNA3 and CHRNB4 are epigenetically deregulated in lung tumorigenesis Cancer Research. 70: 4946-4946. DOI: 10.1158/1538-7445.Am10-4946 |
0.491 |
|
| 2010 |
Wan S, Doong T, Chen H, Alder H, Plass C, Fong LYY. Abstract 146: Zinc deficiency and G0s2 DNA methylation in rat esophageal carcinogenesis Cancer Research. 70: 146-146. DOI: 10.1158/1538-7445.Am10-146 |
0.461 |
|
| 2010 |
Goeppert B, Schmezer P, Breinig M, Warth A, Vogel M, Mittelbronn M, Gdynia G, Breuhahn K, Popanda O, Plass C, Schirmacher P, Kern M. Epigenetic Regulation of Tumor Suppressor AKAP12 in Human Hepatocellular Carcinoma Zeitschrift FüR Gastroenterologie. 48. DOI: 10.1055/S-0029-1246404 |
0.363 |
|
| 2009 |
Chen SS, Sherman MH, Hertlein E, Johnson AJ, Teitell MA, Byrd JC, Plass C. Epigenetic alterations in a murine model for chronic lymphocytic leukemia. Cell Cycle (Georgetown, Tex.). 8: 3663-7. PMID 19901553 DOI: 10.4161/Cc.8.22.9957 |
0.412 |
|
| 2009 |
Chen SS, Raval A, Johnson AJ, Hertlein E, Liu TH, Jin VX, Sherman MH, Liu SJ, Dawson DW, Williams KE, Lanasa M, Liyanarachchi S, Lin TS, Marcucci G, Pekarsky Y, ... ... Plass C, et al. Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America. 106: 13433-8. PMID 19666576 DOI: 10.1073/Pnas.0906455106 |
0.564 |
|
| 2009 |
Kaaks R, Stattin P, Villar S, Poetsch AR, Dossus L, Nieters A, Riboli E, Palmqvist R, Hallmans G, Plass C, Friesen MD. Insulin-like growth factor-II methylation status in lymphocyte DNA and colon cancer risk in the Northern Sweden Health and Disease cohort. Cancer Research. 69: 5400-5. PMID 19549920 DOI: 10.1158/0008-5472.Can-08-3020 |
0.509 |
|
| 2009 |
Liu Z, Wu J, Xie Z, Liu S, Fan-Havard P, Huang TH, Plass C, Marcucci G, Chan KK. Quantification of regional DNA methylation by liquid chromatography/tandem mass spectrometry. Analytical Biochemistry. 391: 106-13. PMID 19442645 DOI: 10.1016/J.Ab.2009.05.012 |
0.522 |
|
| 2009 |
Lin M, Morrison CD, Jones S, Mohamed N, Bacher J, Plass C. Copy number gain and oncogenic activity of YWHAZ/14-3-3zeta in head and neck squamous cell carcinoma. International Journal of Cancer. 125: 603-11. PMID 19405126 DOI: 10.1002/Ijc.24346 |
0.425 |
|
| 2009 |
Yu J, Ershler M, Yu L, Wei M, Hackanson B, Yokohama A, Mitsui T, Liu C, Mao H, Liu S, Liu Z, Trotta R, Liu CG, Liu X, Huang K, ... ... Plass C, et al. TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia. Blood. 113: 5558-67. PMID 19329776 DOI: 10.1182/Blood-2009-02-205732 |
0.469 |
|
| 2009 |
Liu Z, Liu S, Xie Z, Pavlovicz RE, Wu J, Chen P, Aimiuwu J, Pang J, Bhasin D, Neviani P, Fuchs JR, Plass C, Li PK, Li C, Huang TH, et al. Modulation of DNA methylation by a sesquiterpene lactone parthenolide. The Journal of Pharmacology and Experimental Therapeutics. 329: 505-14. PMID 19201992 DOI: 10.1124/Jpet.108.147934 |
0.53 |
|
| 2009 |
Flotho C, Claus R, Batz C, Schneider M, Sandrock I, Ihde S, Plass C, Niemeyer CM, Lübbert M. The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells. Leukemia. 23: 1019-28. PMID 19194470 DOI: 10.1038/Leu.2008.397 |
0.495 |
|
| 2009 |
Bennett KL, Romigh T, Arab K, Teresi RE, Tada Y, Eng C, Plass C. Activator protein 2 alpha (AP2alpha) suppresses 42 kDa C/CAAT enhancer binding protein alpha (p42(C/EBPalpha)) in head and neck squamous cell carcinoma. International Journal of Cancer. 124: 1285-92. PMID 19089912 DOI: 10.1002/Ijc.24087 |
0.794 |
|
| 2009 |
Jun P, Hong C, Lal A, Wong JM, McDermott MW, Bollen AW, Plass C, Held WA, Smiraglia DJ, Costello JF. Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific. Neuro-Oncology. 11: 414-22. PMID 19001526 DOI: 10.1215/15228517-2008-096 |
0.506 |
|
| 2009 |
Brena RM, Plass C. Bio-COBRA: absolute quantification of DNA methylation in electrofluidics chips. Methods in Molecular Biology (Clifton, N.J.). 507: 257-69. PMID 18987820 DOI: 10.1007/978-1-59745-522-0_19 |
0.511 |
|
| 2009 |
Costello JF, Hong C, Plass C, Smiraglia DJ. Restriction landmark genomic scanning: analysis of CpG islands in genomes by 2D gel electrophoresis. Methods in Molecular Biology (Clifton, N.J.). 507: 131-48. PMID 18987812 DOI: 10.1007/978-1-59745-522-0_11 |
0.485 |
|
| 2009 |
Oakes CC, Park YJ, Boutros M, Plass C. Abstract B6: Revealing DAPK1 transcriptional regulation by RNA interference screening with an integrated BAC‐reporter system Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-B6 |
0.426 |
|
| 2009 |
Plass C. Global DNA promoter methylation in cancer Toxicology Letters. 189: S16. DOI: 10.1016/j.toxlet.2009.06.004 |
0.395 |
|
| 2008 |
Plass C, Oakes C, Blum W, Marcucci G. Epigenetics in acute myeloid leukemia. Seminars in Oncology. 35: 378-87. PMID 18692688 DOI: 10.1053/J.Seminoncol.2008.04.008 |
0.366 |
|
| 2008 |
Singer GA, Wu J, Yan P, Plass C, Huang TH, Davuluri RV. Genome-wide analysis of alternative promoters of human genes using a custom promoter tiling array. Bmc Genomics. 9: 349. PMID 18655706 DOI: 10.1186/1471-2164-9-349 |
0.412 |
|
| 2008 |
Whitman SP, Hackanson B, Liyanarachchi S, Liu S, Rush LJ, Maharry K, Margeson D, Davuluri R, Wen J, Witte T, Yu L, Liu C, Bloomfield CD, Marcucci G, Plass C, et al. DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication. Blood. 112: 2013-6. PMID 18566324 DOI: 10.1182/Blood-2008-01-128595 |
0.535 |
|
| 2008 |
Bennett KL, Karpenko M, Lin MT, Claus R, Arab K, Dyckhoff G, Plinkert P, Herpel E, Smiraglia D, Plass C. Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma. Cancer Research. 68: 4494-9. PMID 18559491 DOI: 10.1158/0008-5472.Can-07-6509 |
0.8 |
|
| 2008 |
Schmezer P, Plass C. [Epigenetic aspects in carcinomas of the head and neck]. Hno. 56: 594-602. PMID 18483718 DOI: 10.1007/S00106-008-1720-3 |
0.476 |
|
| 2008 |
Hackanson B, Bennett KL, Brena RM, Jiang J, Claus R, Chen SS, Blagitko-Dorfs N, Maharry K, Whitman SP, Schmittgen TD, Lübbert M, Marcucci G, Bloomfield CD, Plass C. Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia. Cancer Research. 68: 3142-51. PMID 18451139 DOI: 10.1158/0008-5472.Can-08-0483 |
0.772 |
|
| 2008 |
Risch A, Plass C. Lung cancer epigenetics and genetics. International Journal of Cancer. 123: 1-7. PMID 18425819 DOI: 10.1002/Ijc.23605 |
0.365 |
|
| 2008 |
Wang SS, Smiraglia DJ, Wu YZ, Ghosh S, Rader JS, Cho KR, Bonfiglio TA, Nayar R, Plass C, Sherman ME. Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. Cancer Research. 68: 2489-97. PMID 18381458 DOI: 10.1158/0008-5472.Can-07-3194 |
0.527 |
|
| 2008 |
Davuluri RV, Suzuki Y, Sugano S, Plass C, Huang TH. The functional consequences of alternative promoter use in mammalian genomes. Trends in Genetics : Tig. 24: 167-77. PMID 18329129 DOI: 10.1016/J.Tig.2008.01.008 |
0.41 |
|
| 2008 |
Chen S, Johnson AJ, Claus R, Sablitzky F, Plass C, Byrd JC. Loss of Id4 Accelerates CLL Progression in TCL1 Mice Blood. 112: 3153-3153. DOI: 10.1182/Blood.V112.11.3153.3153 |
0.391 |
|
| 2008 |
Lin M, Morrison CD, Jones S, Mohamed N, Bacher J, Plass C. 14-3-3ζ is Amplified, Overexpressed and Possesses Oncogenic Activities in Head and Neck Squamous Cell Carcinoma Nature Precedings. 3: 1-1. DOI: 10.1038/Npre.2008.1953.1 |
0.454 |
|
| 2008 |
Tada Y, Yokomizo A, Kuroiwa K, Tsunoda T, Uchino H, Plass C, Naito S. THE ASSOCIATION OF TLX3 METHYLATION WITH RESISTANCE TO CISPLATIN IN BLADDER CANCER Journal of Urology. 179: 372-372. DOI: 10.1016/S0022-5347(08)61089-7 |
0.394 |
|
| 2007 |
Smiraglia DJ, Kazhiyur-Mannar R, Oakes CC, Wu YZ, Liang P, Ansari T, Su J, Rush LJ, Smith LT, Yu L, Liu C, Dai Z, Chen SS, Wang SH, Costello J, ... ... Plass C, et al. Restriction landmark genomic scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinations. Bmc Genomics. 8: 446. PMID 18053125 DOI: 10.1186/1471-2164-8-446 |
0.71 |
|
| 2007 |
Smith JF, Mahmood S, Song F, Morrow A, Smiraglia D, Zhang X, Rajput A, Higgins MJ, Krumm A, Petrelli NJ, Costello JF, Nagase H, Plass C, Held WA. Identification of DNA methylation in 3' genomic regions that are associated with upregulation of gene expression in colorectal cancer. Epigenetics. 2: 161-72. PMID 17965620 DOI: 10.4161/Epi.2.3.4805 |
0.571 |
|
| 2007 |
Plass C, Byrd JC, Raval A, Tanner SM, de la Chapelle A. Molecular profiling of chronic lymphocytic leukaemia: genetics meets epigenetics to identify predisposing genes. British Journal of Haematology. 139: 744-52. PMID 17961188 DOI: 10.1111/J.1365-2141.2007.06875.X |
0.334 |
|
| 2007 |
Opavsky R, Wang SH, Trikha P, Raval A, Huang Y, Wu YZ, Rodriguez B, Keller B, Liyanarachchi S, Wei G, Davuluri RV, Weinstein M, Felsher D, Ostrowski M, Leone G, ... Plass C, et al. CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells. Plos Genetics. 3: 1757-69. PMID 17907813 DOI: 10.1371/Journal.Pgen.0030167 |
0.55 |
|
| 2007 |
Smith LT, Otterson GA, Plass C. Unraveling the epigenetic code of cancer for therapy. Trends in Genetics : Tig. 23: 449-56. PMID 17681396 DOI: 10.1016/J.Tig.2007.07.005 |
0.477 |
|
| 2007 |
Raval A, Tanner SM, Byrd JC, Angerman EB, Perko JD, Chen SS, Hackanson B, Grever MR, Lucas DM, Matkovic JJ, Lin TS, Kipps TJ, Murray F, Weisenburger D, Sanger W, ... ... Plass C, et al. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell. 129: 879-90. PMID 17540169 DOI: 10.1016/J.Cell.2007.03.043 |
0.434 |
|
| 2007 |
Wu J, Wang SH, Potter D, Liu JC, Smith LT, Wu YZ, Huang TH, Plass C. Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing. Bmc Genomics. 8: 131. PMID 17524140 DOI: 10.1186/1471-2164-8-131 |
0.519 |
|
| 2007 |
Bennett KL, Hackanson B, Smith LT, Morrison CD, Lang JC, Schuller DE, Weber F, Eng C, Plass C. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma. Cancer Research. 67: 4657-64. PMID 17510391 DOI: 10.1158/0008-5472.Can-06-4793 |
0.812 |
|
| 2007 |
Allegrucci C, Wu YZ, Thurston A, Denning CN, Priddle H, Mummery CL, Ward-van Oostwaard D, Andrews PW, Stojkovic M, Smith N, Parkin T, Jones ME, Warren G, Yu L, Brena RM, ... Plass C, et al. Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome. Human Molecular Genetics. 16: 1253-68. PMID 17409196 DOI: 10.1093/Hmg/Ddm074 |
0.406 |
|
| 2007 |
Brena RM, Morrison C, Liyanarachchi S, Jarjoura D, Davuluri RV, Otterson GA, Reisman D, Glaros S, Rush LJ, Plass C. Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancer. Plos Medicine. 4: e108. PMID 17388669 DOI: 10.1371/Journal.Pmed.0040108 |
0.387 |
|
| 2007 |
Dawson DW, Hong JS, Shen RR, French SW, Troke JJ, Wu YZ, Chen SS, Gui D, Regelson M, Marahrens Y, Morse HC, Said J, Plass C, Teitell MA. Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas. Oncogene. 26: 4243-52. PMID 17260020 DOI: 10.1038/Sj.Onc.1210211 |
0.45 |
|
| 2007 |
Park J, Brena RM, Gruidl M, Zhou J, Huang T, Plass C, Tockman MS. CpG island hypermethylation profiling of lung cancer using restriction landmark genomic scanning (RLGS) analysis. Cancer Biomarkers : Section a of Disease Markers. 1: 193-200. PMID 17192040 DOI: 10.3233/Cbm-2005-12-307 |
0.476 |
|
| 2007 |
Brena RM, Huang TH, Plass C. Toward a human epigenome. Nature Genetics. 38: 1359-60. PMID 17133218 DOI: 10.1038/Ng1206-1359 |
0.439 |
|
| 2007 |
Hackanson B, Bennett KL, Brena RM, Jiang J, Maharry K, Whitman SP, Schmittgen TD, Luebbert M, Marcucci G, Bloomfield CD, Plass C. Dual Epigenetic Control of CCAAT/Enhancer Binding Protein α (C/EBPα) Expression in Acute Myeloid Leukemia. Blood. 110: 2116-2116. DOI: 10.1182/Blood.V110.11.2116.2116 |
0.82 |
|
| 2006 |
Brena RM, Auer H, Kornacker K, Plass C. Quantification of DNA methylation in electrofluidics chips (Bio-COBRA). Nature Protocols. 1: 52-8. PMID 17406211 DOI: 10.1038/Nprot.2006.8 |
0.519 |
|
| 2006 |
Brena RM, Plass C, Costello JF. Mining methylation for early detection of common cancers Plos Medicine. 3: 2184-2185. PMID 17194184 DOI: 10.1371/Journal.Pmed.0030479 |
0.312 |
|
| 2006 |
Plass C, Smiraglia DJ. Genome-wide analysis of DNA methylation changes in human malignancies Current Topics in Microbiology and Immunology. 310: 179-198. PMID 16909911 DOI: 10.1007/3-540-31181-5_9 |
0.52 |
|
| 2006 |
Wu J, Smith LT, Plass C, Huang TH. ChIP-chip comes of age for genome-wide functional analysis. Cancer Research. 66: 6899-902. PMID 16849531 DOI: 10.1158/0008-5472.Can-06-0276 |
0.387 |
|
| 2006 |
Smith LT, Mayerson J, Nowak NJ, Suster D, Mohammed N, Long S, Auer H, Jones S, McKeegan C, Young G, Bos G, Plass C, Morrison C. 20q11.1 amplification in giant-cell tumor of bone: Array CGH, FISH, and association with outcome. Genes, Chromosomes & Cancer. 45: 957-66. PMID 16847944 DOI: 10.1002/Gcc.20354 |
0.361 |
|
| 2006 |
Raval A, Byrd JC, Plass C. Epigenetics in chronic lymphocytic leukemia. Seminars in Oncology. 33: 157-66. PMID 16616062 DOI: 10.1053/J.Seminoncol.2005.12.011 |
0.502 |
|
| 2006 |
Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. Journal of the National Cancer Institute. 98: 396-406. PMID 16537832 DOI: 10.1093/Jnci/Djj093 |
0.434 |
|
| 2006 |
Feltus FA, Lee EK, Costello JF, Plass C, Vertino PM. DNA motifs associated with aberrant CpG island methylation. Genomics. 87: 572-9. PMID 16487676 DOI: 10.1016/J.Ygeno.2005.12.016 |
0.519 |
|
| 2006 |
Brena RM, Auer H, Kornacker K, Hackanson B, Raval A, Byrd JC, Plass C. Accurate quantification of DNA methylation using combined bisulfite restriction analysis coupled with the Agilent 2100 Bioanalyzer platform. Nucleic Acids Research. 34: e17. PMID 16464820 DOI: 10.1093/Nar/Gnj017 |
0.5 |
|
| 2006 |
Cheng AS, Jin VX, Fan M, Smith LT, Liyanarachchi S, Yan PS, Leu YW, Chan MW, Plass C, Nephew KP, Davuluri RV, Huang TH. Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters. Molecular Cell. 21: 393-404. PMID 16455494 DOI: 10.1016/J.Molcel.2005.12.016 |
0.347 |
|
| 2006 |
Liu TH, Raval A, Chen SS, Matkovic JJ, Byrd JC, Plass C. CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia. Cancer Research. 66: 653-8. PMID 16423993 DOI: 10.1158/0008-5472.Can-05-3712 |
0.484 |
|
| 2006 |
Brena RM, Huang TH, Plass C. Quantitative assessment of DNA methylation: Potential applications for disease diagnosis, classification, and prognosis in clinical settings. Journal of Molecular Medicine (Berlin, Germany). 84: 365-77. PMID 16416310 DOI: 10.1007/S00109-005-0034-0 |
0.469 |
|
| 2006 |
Smith LT, Lin M, Brena RM, Lang JC, Schuller DE, Otterson GA, Morrison CD, Smiraglia DJ, Plass C. Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. Proceedings of the National Academy of Sciences of the United States of America. 103: 982-7. PMID 16415157 DOI: 10.1073/Pnas.0510171102 |
0.525 |
|
| 2006 |
Rosenbauer F, Owens BM, Yu L, Tumang JR, Steidl U, Kutok JL, Clayton LK, Wagner K, Scheller M, Iwasaki H, Liu C, Hackanson B, Akashi K, Leutz A, Rothstein TL, ... Plass C, et al. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1. Nature Genetics. 38: 27-37. PMID 16311598 DOI: 10.1038/Ng1679 |
0.439 |
|
| 2006 |
Lin M, Smith LT, Smiraglia DJ, Kazhiyur-Mannar R, Lang JC, Schuller DE, Kornacker K, Wenger R, Plass C. DNA copy number gains in head and neck squamous cell carcinoma. Oncogene. 25: 1424-33. PMID 16247453 DOI: 10.1038/Sj.Onc.1209166 |
0.343 |
|
| 2006 |
Klisovic RB, Blum W, Hackanson B, Kefauver C, Liu S, Liu Z, Chan KK, Plass C, Grever MR, Byrd JC, Marcucci G. Updated results of a phase I study of low dose decitabine and valproic acid (VA) in patients with acute myeloid leukemia (AML): Gene reexpression, demethylation, and clinical response Journal of Clinical Oncology. 24: 6515-6515. DOI: 10.1200/Jco.2006.24.18_Suppl.6515 |
0.333 |
|
| 2006 |
Whitman SP, Wen J, Muto G, Hackanson B, Yu L, Liu C, Sanfilippo JL, Marcucci G, Rush LJ, Plass C, Caligiuri MA. The Tumor Suppressor Gene SLC5A8 Is Selectively Silenced in MLL Partial Tandem Duplication-Positive Acute Myeloid Leukemia with Normal Cytogenetics. Blood. 108: 9-9. DOI: 10.1182/Blood.V108.11.9.9 |
0.571 |
|
| 2006 |
Yu J, Yu L, Hackanson B, Wei M, Boyd Z, Yokohama A, Liu C, Trotta R, Mao HC, Becknell B, Jaung MS, Liu S, Byrd JC, Marcucci G, Plass C, et al. In Vitro and In Vivo Evidence That TSC-22 Is a Putative Tumor Suppressor Gene in Primary Murine and Human Leukemia. Blood. 108: 2211-2211. DOI: 10.1182/Blood.V108.11.2211.2211 |
0.491 |
|
| 2005 |
Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, Heine-Suñer D, Cigudosa JC, Urioste M, Benitez J, Boix-Chornet M, Sanchez-Aguilera A, Ling C, Carlsson E, Poulsen P, ... ... Plass C, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proceedings of the National Academy of Sciences of the United States of America. 102: 10604-9. PMID 16009939 DOI: 10.1073/Pnas.0500398102 |
0.464 |
|
| 2005 |
Raval A, Lucas DM, Matkovic JJ, Bennett KL, Liyanarachchi S, Young DC, Rassenti L, Kipps TJ, Grever MR, Byrd JC, Plass C. TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 3877-85. PMID 15809452 DOI: 10.1200/Jco.2005.02.196 |
0.786 |
|
| 2005 |
Whitman SP, Liu S, Vukosavljevic T, Rush LJ, Yu L, Liu C, Klisovic MI, Maharry K, Guimond M, Strout MP, Becknell B, Dorrance A, Klisovic RB, Plass C, Bloomfield CD, et al. The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy. Blood. 106: 345-52. PMID 15774615 DOI: 10.1182/Blood-2005-01-0204 |
0.386 |
|
| 2005 |
Liu S, Shen T, Huynh L, Klisovic MI, Rush LJ, Ford JL, Yu J, Becknell B, Li Y, Liu C, Vukosavljevic T, Whitman SP, Chang KS, Byrd JC, Perrotti D, ... Plass C, et al. Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia. Cancer Research. 65: 1277-84. PMID 15735013 DOI: 10.1158/0008-5472.Can-04-4532 |
0.392 |
|
| 2005 |
Yu L, Liu C, Vandeusen J, Becknell B, Dai Z, Wu YZ, Raval A, Liu TH, Ding W, Mao C, Liu S, Smith LT, Lee S, Rassenti L, Marcucci G, ... ... Plass C, et al. Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nature Genetics. 37: 265-74. PMID 15723065 DOI: 10.1038/Ng1521 |
0.792 |
|
| 2005 |
Owens BM, Yu L, Steidl U, Kutok JL, Clayton LK, Wagner K, Iwasaki H, Liu C, Hackanson B, Akashi K, Plass C, Tenen DG, Rosenbauer F. Identification of ID4 as a Cooperating Second Hit for T Cell Lymphoma Development in PU.1 UREΔ/Δ Mice. Blood. 106: 2613-2613. DOI: 10.1182/Blood.V106.11.2613.2613 |
0.501 |
|
| 2005 |
Tockman M, Park J, Chen L, Zhou J, Brena R, Chan M, Huang T, Plass C. P-279 Lung cancer-specific biomarkers of tumor suppressor gene silencing Lung Cancer. 49: S188. DOI: 10.1016/S0169-5002(05)80773-1 |
0.371 |
|
| 2005 |
Huang THM, Plass C, Liang G, Laird PW. Epi meets genomics: Technologies for finding and reading the 5th base The Epigenome: Molecular Hide and Seek. 39-64. DOI: 10.1002/3527601511.ch3 |
0.361 |
|
| 2004 |
Pompeia C, Hodge DR, Peng B, Plass C, Wu YZ, Farrar WL. Epigenetic Up-regulation of Gene Expression in KAS 6/1 Human Multiple Myeloma Cells. Cancer Genomics & Proteomics. 1: 387-406. PMID 31394631 |
0.434 |
|
| 2004 |
Leu YW, Yan PS, Fan M, Jin VX, Liu JC, Curran EM, Welshons WV, Wei SH, Davuluri RV, Plass C, Nephew KP, Huang TH. Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer. Cancer Research. 64: 8184-92. PMID 15548683 DOI: 10.1158/0008-5472.Can-04-2045 |
0.49 |
|
| 2004 |
Weber F, Aldred MA, Morrison CD, Plass C, Frilling A, Broelsch CE, Waite KA, Eng C. Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis. The Journal of Clinical Endocrinology and Metabolism. 90: 1149-55. PMID 15546898 DOI: 10.1210/Jc.2004-1447 |
0.438 |
|
| 2004 |
Yu L, Liu C, Bennett K, Wu YZ, Dai Z, Vandeusen J, Opavsky R, Raval A, Trikha P, Rodriguez B, Becknell B, Mao C, Lee S, Davuluri RV, Leone G, ... ... Plass C, et al. A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies. Genomics. 84: 647-60. PMID 15475242 DOI: 10.1016/J.Ygeno.2004.06.010 |
0.831 |
|
| 2004 |
Pompeia C, Hodge DR, Plass C, Wu YZ, Marquez VE, Kelley JA, Farrar WL. Microarray analysis of epigenetic silencing of gene expression in the KAS-6/1 multiple myeloma cell line. Cancer Research. 64: 3465-73. PMID 15150099 DOI: 10.1158/0008-5472.Can-03-3970 |
0.549 |
|
| 2004 |
Dai Z, Popkie AP, Zhu WG, Timmers CD, Raval A, Tannehill-Gregg S, Morrison CD, Auer H, Kratzke RA, Niehans G, Amatschek S, Sommergruber W, Leone GW, Rosol T, Otterson GA, ... Plass C, et al. Bone morphogenetic protein 3B silencing in non-small-cell lung cancer. Oncogene. 23: 3521-9. PMID 15116090 DOI: 10.1038/Sj.Onc.1207441 |
0.741 |
|
| 2004 |
Rush LJ, Raval A, Funchain P, Johnson AJ, Smith L, Lucas DM, Bembea M, Liu TH, Heerema NA, Rassenti L, Liyanarachchi S, Davuluri R, Byrd JC, Plass C. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets. Cancer Research. 64: 2424-33. PMID 15059895 DOI: 10.1158/0008-5472.Can-03-2870 |
0.547 |
|
| 2004 |
Zhu WG, Hileman T, Ke Y, Wang P, Lu S, Duan W, Dai Z, Tong T, Villalona-Calero MA, Plass C, Otterson GA. 5-aza-2'-deoxycytidine activates the p53/p21Waf1/Cip1 pathway to inhibit cell proliferation. The Journal of Biological Chemistry. 279: 15161-6. PMID 14722112 DOI: 10.1074/Jbc.M311703200 |
0.69 |
|
| 2004 |
Smith LT, Plass C. DNA methylation leaves its mark in head and neck squamous cell carcinomas (HNSCC) Current Genomics. 5: 489-498. DOI: 10.2174/1389202043348940 |
0.46 |
|
| 2004 |
Yu L, Liu C, Vandeusen J, Becknell B, Dai Z, Wu Y, Raval A, Liu T, Ding W, Mao C, Liu S, Smith LT, Lee S, Rassenti L, Marcucci G, ... ... Plass C, et al. Global Assessment of Promoter Methylation in a Murine Model of Cancer Identifies ID4 as a Putative Novel Tumor Suppressor Gene in Human Leukemia. Blood. 104: 3488-3488. DOI: 10.1182/Blood.V104.11.3488.3488 |
0.76 |
|
| 2004 |
Motiwala T, Ghoshal K, Majumder S, Kutay H, Neuberg DS, Kitada S, Reed JC, Dewald GW, Flinn IW, Tallman MA, Liu T, Plass C, Lucas DM, Byrd JC, Jacob ST, et al. Methylation of the Tumor Suppressor Gene PTPRO (Receptor-Type Protein Tyrosine Phosphatase) Is Associated with Expression of Important Apoptosis-Related Proteins in Chronic Lymphocytic Leukemia (CLL). Blood. 104: 2804-2804. DOI: 10.1182/Blood.V104.11.2804.2804 |
0.537 |
|
| 2004 |
Lenschen T, Mühlisch J, Jürgens H, Plass C, Smiraglia D, Frühwald M. In depth analysis of aberrantly methylated genes detected by genome scanning in medulloblastoma and other malignancies of the CNS Klinische PäDiatrie. 216. DOI: 10.1055/S-2004-828580 |
0.346 |
|
| 2003 |
Feltus FA, Lee EK, Costello JF, Plass C, Vertino PM. Predicting aberrant CpG island methylation Proceedings of the National Academy of Sciences of the United States of America. 100: 12253-12258. PMID 14519846 DOI: 10.1073/Pnas.2037852100 |
0.541 |
|
| 2003 |
Li J, Zhang Z, Dai Z, Popkie AP, Plass C, Morrison C, Wang Y, You M. RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancer. Neoplasia (New York, N.Y.). 5: 362-6. PMID 14511407 DOI: 10.1016/S1476-5586(03)80029-5 |
0.722 |
|
| 2003 |
Motiwala T, Ghoshal K, Das A, Majumder S, Weichenhan D, Wu YZ, Holman K, James SJ, Jacob ST, Plass C. Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas. Oncogene. 22: 6319-31. PMID 14508512 DOI: 10.1038/Sj.Onc.1206750 |
0.513 |
|
| 2003 |
Richard V, Luchin A, Brena RM, Plass C, Rosol TJ. Quantitative evaluation of alternative promoter usage and 3' splice variants for parathyroid hormone-related protein by real-time reverse transcription-PCR. Clinical Chemistry. 49: 1398-402. PMID 12881458 DOI: 10.1373/49.8.1398 |
0.402 |
|
| 2003 |
Li H, Myeroff L, Smiraglia D, Romero MF, Pretlow TP, Kasturi L, Lutterbaugh J, Rerko RM, Casey G, Issa JP, Willis J, Willson JK, Plass C, Markowitz SD. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proceedings of the National Academy of Sciences of the United States of America. 100: 8412-7. PMID 12829793 DOI: 10.1073/Pnas.1430846100 |
0.539 |
|
| 2003 |
Zhu WG, Srinivasan K, Dai Z, Duan W, Druhan LJ, Ding H, Yee L, Villalona-Calero MA, Plass C, Otterson GA. Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter. Molecular and Cellular Biology. 23: 4056-65. PMID 12773551 DOI: 10.1128/Mcb.23.12.4056-4065.2003 |
0.719 |
|
| 2003 |
Smiraglia DJ, Plass C. The development of CpG island methylation biomarkers using restriction landmark genomic scanning. Annals of the New York Academy of Sciences. 983: 110-9. PMID 12724216 DOI: 10.1111/J.1749-6632.2003.Tb05966.X |
0.522 |
|
| 2003 |
Dai Z, Zhu WG, Morrison CD, Brena RM, Smiraglia DJ, Raval A, Wu YZ, Rush LJ, Ross P, Molina JR, Otterson GA, Plass C. A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes. Human Molecular Genetics. 12: 791-801. PMID 12651874 DOI: 10.1093/Hmg/Ddg083 |
0.715 |
|
| 2003 |
Li J, Zhang Z, Dai Z, Plass C, Morrison C, Wang Y, Wiest JS, Anderson MW, You M. LOH of chromosome 12p correlates with Kras2 mutation in non-small cell lung cancer. Oncogene. 22: 1243-6. PMID 12606951 DOI: 10.1038/Sj.Onc.1206192 |
0.69 |
|
| 2003 |
Klisovic MI, Maghraby EA, Parthun MR, Guimond M, Sklenar AR, Whitman SP, Chan KK, Murphy T, Anon J, Archer KJ, Rush LJ, Plass C, Grever MR, Byrd JC, Marcucci G. Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells Leukemia. 17: 350-358. PMID 12592335 DOI: 10.1038/Sj.Leu.2402776 |
0.447 |
|
| 2003 |
Oakes CC, Smiraglia DJ, Plass C, Trasler JM, Robaire B. Aging results in hypermethylation of ribosomal DNA in sperm and liver of male rats. Proceedings of the National Academy of Sciences of the United States of America. 100: 1775-80. PMID 12574505 DOI: 10.1073/Pnas.0437971100 |
0.428 |
|
| 2003 |
Smiraglia DJ, Smith LT, Lang JC, Rush LJ, Dai Z, Schuller DE, Plass C. Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC). Journal of Medical Genetics. 40: 25-33. PMID 12525538 DOI: 10.1136/Jmg.40.1.25 |
0.748 |
|
| 2003 |
Plass C. Cancer epigenomics. Human Molecular Genetics. 11: 2479-88. PMID 12351584 DOI: 10.1093/hmg/11.20.2479 |
0.463 |
|
| 2002 |
Dai Z, Weichenhan D, Wu YZ, Hall JL, Rush LJ, Smith LT, Raval A, Yu L, Kroll D, Muehlisch J, Frühwald MC, de Jong P, Catanese J, Davuluri RV, Smiraglia DJ, ... Plass C, et al. An AscI boundary library for the studies of genetic and epigenetic alterations in CpG islands. Genome Research. 12: 1591-8. PMID 12368252 DOI: 10.1101/Gr.197402 |
0.781 |
|
| 2002 |
Rush LJ, Plass C. Restriction landmark genomic scanning for DNA methylation in cancer: past, present, and future applications. Analytical Biochemistry. 307: 191-201. PMID 12202234 DOI: 10.1016/S0003-2697(02)00033-7 |
0.536 |
|
| 2002 |
Smiraglia DJ, Plass C. The study of aberrant methylation in cancer via restriction landmark genomic scanning. Oncogene. 21: 5414-26. PMID 12154404 DOI: 10.1038/Sj.Onc.1205608 |
0.529 |
|
| 2002 |
Rush LJ, Plass C. Alterations of DNA methylation in hematologic malignancies. Cancer Letters. 185: 1-12. PMID 12142073 DOI: 10.1016/S0304-3835(02)00288-4 |
0.572 |
|
| 2002 |
de la Puente A, Hall J, Wu YZ, Leone G, Peters J, Yoon BJ, Soloway P, Plass C. Structural characterization of Rasgrf1 and a novel linked imprinted locus. Gene. 291: 287-97. PMID 12095702 DOI: 10.1016/S0378-1119(02)00601-7 |
0.42 |
|
| 2002 |
Costello JF, Smiraglia DJ, Plass C. Restriction landmark genome scanning. Methods (San Diego, Calif.). 27: 144-9. PMID 12095273 DOI: 10.1016/S1046-2023(02)00067-1 |
0.562 |
|
| 2002 |
Smiraglia DJ, Szymanska J, Kraggerud SM, Lothe RA, Peltomäki P, Plass C. Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors. Oncogene. 21: 3909-16. PMID 12032829 DOI: 10.1038/Sj.Onc.1205488 |
0.503 |
|
| 2002 |
Moinova HR, Chen WD, Shen L, Smiraglia D, Olechnowicz J, Ravi L, Kasturi L, Myeroff L, Plass C, Parsons R, Minna J, Willson JK, Green SB, Issa JP, Markowitz SD. HLTF gene silencing in human colon cancer. Proceedings of the National Academy of Sciences of the United States of America. 99: 4562-7. PMID 11904375 DOI: 10.1073/Pnas.062459899 |
0.491 |
|
| 2002 |
Plass C, Soloway PD. DNA methylation, imprinting and cancer. European Journal of Human Genetics : Ejhg. 10: 6-16. PMID 11896451 DOI: 10.1038/Sj.Ejhg.5200768 |
0.535 |
|
| 2002 |
Majumder S, Ghoshal K, Datta J, Bai S, Dong X, Quan N, Plass C, Jacob ST. Role of de novo DNA methyltransferases and methyl CpG-binding proteins in gene silencing in a rat hepatoma. The Journal of Biological Chemistry. 277: 16048-58. PMID 11844796 DOI: 10.1074/Jbc.M111662200 |
0.51 |
|
| 2002 |
Frühwald MC, Plass C. Global and gene-specific methylation patterns in cancer: aspects of tumor biology and clinical potential. Molecular Genetics and Metabolism. 75: 1-16. PMID 11825059 DOI: 10.1006/Mgme.2001.3265 |
0.557 |
|
| 2002 |
Yoon BJ, Herman H, Sikora A, Smith LT, Plass C, Soloway PD. Regulation of DNA methylation of Rasgrf1. Nature Genetics. 30: 92-6. PMID 11753386 DOI: 10.1038/Ng795 |
0.548 |
|
| 2001 |
Zhu WG, Dai Z, Ding H, Srinivasan K, Hall J, Duan W, Villalona-Calero MA, Plass C, Otterson GA. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells. Oncogene. 20: 7787-96. PMID 11753657 DOI: 10.1038/Sj.Onc.1204970 |
0.779 |
|
| 2001 |
Tanner SM, Austin JL, Leone G, Rush LJ, Plass C, Heinonen K, Mrózek K, Sill H, Knuutila S, Kolitz JE, Archer KJ, Caligiuri MA, Bloomfield CD, de La Chapelle A. BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia. Proceedings of the National Academy of Sciences of the United States of America. 98: 13901-6. PMID 11707601 DOI: 10.1073/Pnas.241525498 |
0.389 |
|
| 2001 |
Dai Z, Lakshmanan RR, Zhu WG, Smiraglia DJ, Rush LJ, Frühwald MC, Brena RM, Li B, Wright FA, Ross P, Otterson GA, Plass C. Global methylation profiling of lung cancer identifies novel methylated genes. Neoplasia (New York, N.Y.). 3: 314-23. PMID 11571631 DOI: 10.1038/Sj.Neo.7900162 |
0.784 |
|
| 2001 |
Frühwald MC, O'Dorisio MS, Smith L, Dai Z, Wright FA, Paulus W, Jürgens H, Plass C. [Hypermethylation as a potential prognostic factor and a clue to a better understanding of the molecular pathogenesis of medulloblastoma--results of a genomewide methylation scan]. Klinische PäDiatrie. 213: 197-203. PMID 11528554 DOI: 10.1055/S-2001-16851 |
0.743 |
|
| 2001 |
Frühwald MC, O'Dorisio MS, Dai Z, Tanner SM, Balster DA, Gao X, Wright FA, Plass C. Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility. Oncogene. 20: 5033-42. PMID 11526488 DOI: 10.1038/Sj.Onc.1204613 |
0.786 |
|
| 2001 |
Smiraglia DJ, Rush LJ, Frühwald MC, Dai Z, Held WA, Costello JF, Lang JC, Eng C, Li B, Wright FA, Caligiuri MA, Plass C. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies Human Molecular Genetics. 10: 1413-1419. PMID 11440994 DOI: 10.1093/Hmg/10.13.1413 |
0.733 |
|
| 2001 |
Rush LJ, Dai Z, Smiraglia DJ, Gao X, Wright FA, Frühwald M, Costello JF, Held WA, Yu L, Krahe R, Kolitz JE, Bloomfield CD, Caligiuri MA, Plass C. Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci. Blood. 97: 3226-33. PMID 11342453 DOI: 10.1182/Blood.V97.10.3226 |
0.774 |
|
| 2001 |
Costello JF, Plass C. Methylation matters. Journal of Medical Genetics. 38: 285-303. PMID 11333864 DOI: 10.1136/jmg.38.5.285 |
0.446 |
|
| 2001 |
Frühwald MC, O'Dorisio MS, Dai Z, Rush LJ, Krahe R, Smiraglia DJ, Pietsch T, Elsea SH, Plass C. Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs. Genes, Chromosomes & Cancer. 30: 38-47. PMID 11107174 DOI: 10.1002/1098-2264(2000)9999:9999<::Aid-Gcc1052>3.0.Co;2-S |
0.757 |
|
| 2001 |
Nakagawa H, Chadwick RB, Peltomaki P, Plass C, Nakamura Y, de la Chapelle A. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer Proceedings of the National Academy of Sciences. 98: 591-596. DOI: 10.1073/Pnas.98.2.591 |
0.394 |
|
| 2001 |
Plass C, Frühwald MC, Rush LJ, Dai Z, Smith LT, Smiraglia DJ. Contribution of DNA methylation to oncogenesis: Results of a genome scanning approach in multiple human tumors Nature Genetics. 27: 80-80. DOI: 10.1038/87252 |
0.748 |
|
| 2001 |
Gimm O, Dziema H, Brown J, De La Puente A, Hoang-Vu C, Dralle H, Plass C, Eng C. Mutation analysis ofNTRK2 andNTRK3, encoding 2 tyrosine kinase receptors, in sporadic human medullary thyroid carcinoma reveals novel sequence variants International Journal of Cancer. 92: 70-74. DOI: 10.1002/1097-0215(200102)9999:9999<::Aid-Ijc1153>3.0.Co;2-N |
0.329 |
|
| 2000 |
Costello JF, Plass C, Cavenee WK. Aberrant methylation of genes in low-grade astrocytomas. Brain Tumor Pathology. 17: 49-56. PMID 11210171 DOI: 10.1007/Bf02482735 |
0.538 |
|
| 2000 |
Haddad R, Morrow AD, Plass C, Held WA. Restriction landmark genomic scanning of mouse liver tumors for gene amplification: Overexpression of cyclin A2 Biochemical and Biophysical Research Communications. 274: 188-196. PMID 10903917 DOI: 10.1006/Bbrc.2000.3124 |
0.361 |
|
| 2000 |
Zhou XP, Smith WM, Gimm O, Mueller E, Gao X, Sarraf P, Prior TW, Plass C, von Deimling A, Black PM, Yates AJ, Eng C. Over-representation of PPARgamma sequence variants in sporadic cases of glioblastoma multiforme: preliminary evidence for common low penetrance modifiers for brain tumour risk in the general population. Journal of Medical Genetics. 37: 410-4. PMID 10851250 DOI: 10.1136/Jmg.37.6.410 |
0.322 |
|
| 2000 |
Ying AK, Hassanain HH, Roos CM, Smiraglia DJ, Issa JPJ, Michler RE, Caligiuri M, Plass C, Goldschmidt-Clermont PJ. Methylation of the estrogen receptor-α gene promoter is selectively increased in proliferating human aortic smooth muscle cells Cardiovascular Research. 46: 172-179. PMID 10727665 DOI: 10.1016/S0008-6363(00)00004-3 |
0.431 |
|
| 2000 |
Costello JF, Frühwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomäki P, Lang JC, Schuller DE, Yu L, Bloomfield CD, Caligiuri MA, Yates A, ... ... Plass C, et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nature Genetics. 24: 132-8. PMID 10655057 DOI: 10.1038/72785 |
0.525 |
|
| 1999 |
Smiraglia DJ, Frühwald MC, Costello JF, McCormick SP, Dai Z, Peltomäki P, O'Dorisio MS, Cavenee WK, Plass C. A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from restriction landmark genome scanning gels. Genomics. 58: 254-62. PMID 10373323 DOI: 10.1006/Geno.1999.5840 |
0.727 |
|
| 1999 |
Plass C, Yu F, Yu L, Strout MP, El-Rifai W, Elonen E, Knuutila S, Marcucci G, Young DC, Held WA, Bloomfield CD, Caligiuri MA. Restriction landmark genome scanning for aberrant methylation in primary refractory and relapsed acute myeloid leukemia; involvement of the WIT-1 gene. Oncogene. 18: 3159-65. PMID 10340388 DOI: 10.1038/Sj.Onc.1202651 |
0.457 |
|
| 1999 |
Pearsall RS, Plass C, Romano MA, Garrick MD, Shibata H, Hayashizaki Y, Held WA. A direct repeat sequence at the Rasgrf1 locus and imprinted expression. Genomics. 55: 194-201. PMID 9933566 DOI: 10.1006/Geno.1998.5660 |
0.484 |
|
| 1998 |
Shibata H, Yoda Y, Kato R, Ueda T, Kamiya M, Hiraiwa N, Yoshiki A, Plass C, Pearsall RS, Held WA, Muramatsu M, Sasaki H, Kusakabe M, Hayashizaki Y. A methylation imprint mark in the mouse imprinted gene Grf1/Cdc25Mm locus shares a common feature with the U2afbp-rs gene: an association with a short tandem repeat and a hypermethylated region. Genomics. 49: 30-7. PMID 9570946 DOI: 10.1006/Geno.1998.5218 |
0.449 |
|
| 1997 |
Shibata H, Ueda T, Kamiya M, Yoshiki A, Kusakabe M, Plass C, Held WA, Sunahara S, Katsuki M, Muramatsu M, Hayashizaki Y. An oocyte-specific methylation imprint center in the mouse U2afbp-rs/U2af1-rs1 gene marks the establishment of allele-specific methylation during preimplantation development. Genomics. 44: 171-8. PMID 9299233 DOI: 10.1006/Geno.1997.4877 |
0.429 |
|
| 1996 |
Shibata H, Yoshino K, Sunahara S, Gondo Y, Katsuki M, Ueda T, Kamiya M, Muramatsu M, Murakami Y, Kalcheva I, Plass C, Chapman VM, Hayashizaki Y. Inactive allele-specific methylation and chromatin structure of the imprinted gene U2af1-rs1 on mouse chromosome 11. Genomics. 35: 248-52. PMID 8661130 DOI: 10.1006/Geno.1996.0348 |
0.401 |
|
| 1996 |
Pearsall RS, Shibata H, Brozowska A, Yoshino K, Okuda K, deJong PJ, Plass C, Chapman VM, Hayashizaki Y, Held WA. Absence of imprinting in U2AFBPL, a human homologue of the imprinted mouse gene U2afbp-rs. Biochemical and Biophysical Research Communications. 222: 171-7. PMID 8630064 DOI: 10.1006/Bbrc.1996.0716 |
0.353 |
|
| 1995 |
Kalcheva ID, Matsuda Y, Plass C, Chapman VM. Isolation and characterization of a pseudoautosomal region-specific genetic marker in C57BL/6 mice using genomic representational difference analysis. Proceedings of the National Academy of Sciences of the United States of America. 92: 12352-6. PMID 8618899 DOI: 10.1073/Pnas.92.26.12352 |
0.314 |
|
| 1995 |
Plass C, Weichenhan D, Kunze B, Hellwig T, Schneider C, Bautz FA, Grzeschik KH, Traut W, Winking H. A member of the mouse LRR transcript family with homology to the human Sp100 gene Hereditas. 122: 245-256. PMID 8537240 DOI: 10.1111/J.1601-5223.1995.00245.X |
0.353 |
|
| 1995 |
Plass C, Kawai J, Kalcheva I, Davis L, Watanabe S, Hayashizaki Y, Chapman V. Comparative analysis of mouse NotI linking clones with mouse and human genomic sequences and transcripts. Dna Research : An International Journal For Rapid Publication of Reports On Genes and Genomes. 2: 27-35. PMID 7788526 DOI: 10.1093/Dnares/2.1.27 |
0.459 |
|
| 1995 |
Okuizumi H, Okazaki Y, Ohsumi T, Hayashizaki Y, Plass C, Chapman VM. Genetic mapping of restriction landmark genomic scanning loci in the mouse. Electrophoresis. 16: 233-40. PMID 7774564 DOI: 10.1002/Elps.1150160139 |
0.31 |
|
| 1995 |
Shibata H, Yoshino K, Muramatsu M, Plass C, Chapman VM, Hayashizaki Y. The use of restriction landmark genomic scanning to scan the mouse genome for endogenous loci with imprinted patterns of methylation. Electrophoresis. 16: 210-7. PMID 7774561 DOI: 10.1002/Elps.1150160136 |
0.372 |
|
| 1994 |
Hayashizaki Y, Shibata H, Hirotsune S, Sugino H, Okazaki Y, Sasaki N, Hirose K, Imoto H, Okuizumi H, Muramatsu M, Komatsubara H, Shiroishi T, Moriwaki K, Katsuki M, Hatano N, ... ... Plass C, et al. Identification of an imprinted U2af binding protein related sequence on mouse chromosome 11 using the RLGS method Nature Genetics. 6: 33-40. PMID 8136831 DOI: 10.1038/Ng0194-33 |
0.376 |
|
| 1993 |
Hirotsune S, Shibata H, Okazaki Y, Sugino H, Imoto H, Sasaki N, Hirose K, Okuizumi H, Muramatsu M, Plass C, Chapman VM, Tamatsukuri S, Miyamoto C, Furuichi Y, Hayashizaki Y. Molecular Cloning of Polymorphic Markers on RLGS Gel Using the Spot Target Cloning Method Biochemical and Biophysical Research Communications. 194: 1406-1412. PMID 8352799 DOI: 10.1006/Bbrc.1993.1981 |
0.384 |
|
| 1992 |
Purmann L, Plass C, Grüneberg M, Winking H, Traut W. A long-range repeat cluster in chromosome 1 of the house mouse, Mus musculus, and its relation to a germline homogeneously staining region. Genomics. 12: 80-8. PMID 1370812 DOI: 10.1016/0888-7543(92)90410-T |
0.304 |
|
| 1991 |
Eckert WA, Plass C, Weith A, Traut W, Winking H. Transcripts from amplified sequences of an inherited homogeneously staining region in chromosome 1 of the house mouse (Mus musculus). Molecular and Cellular Biology. 11: 2229-35. PMID 2005907 DOI: 10.1128/Mcb.11.4.2229 |
0.336 |
|
| Show low-probability matches. |